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Overview 
Internal and external respiration 
 (mt) Mitochondrial catabolic 
respiration, JkO2, is the O2 consumption in 
the oxidation of fuel substrates (electron 
donors) and reduction of O2 catalysed by 
the electron transfer system, ETS, which 
drives the protonmotive force, pmF. JkO2 
excludes mitochondrial residual oxygen 
consumption, mt-Rox (). 
 (ce) Cell respiration or internal 
cellular O2 consumption, JrO2, takes into 
account all chemical reactions, r, that 
consume O2 in the cells. Catabolic cell 
respiration is the O2 consumption 
associated with catabolic pathways in the 
cell, including (mt) mitochondrial 
catabolism; mt-Rox (); non-mt O2 
consumption by catabolic reactions, 
particularly peroxisomal oxidases and 
microsomal cytochrome P450 systems 
(); and non-mt Rox by reactions 
unrelated to catabolism (). 
 (ext) External respiration balances 
internal respiration at steady-state, 
including extracellular Rox () and aerobic respiration by the microbiome ().  
 O2 is transported from the environment across the respiratory cascade, i.e., circulation between 
tissues and diffusion across cell membranes, to the intracellular compartment. The respiratory 
quotient, RQ, is the molar CO2/O2 exchange ratio; when combined with the respiratory nitrogen 
quotient, N/O2 (mol N given off per mol O2 consumed), the RQ reflects the proportion of carbohydrate, 
lipid and protein utilized in cell respiration during aerobically balanced steady-states. Bicarbonate and 
CO2 are transported in reverse to the extracellular milieu and the organismic environment. 
Hemoglobin provides the molecular paradigm for the combination of O2 and CO2 exchange, as do lungs, 
gills, the skin and other surfaces on the morphological level.  
 Respiratory states are defined in Table 1. Rates are illustrated in Figure 5. Consult Table 8 for a 
list of terms and symbols. 
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Abstract 
 
As the knowledge base and importance of 
mitochondrial physiology to evolution, 
health and disease expands, the necessity 
for harmonizing the terminology 
concerning mitochondrial respiratory 
states and rates has become increasingly 
apparent. The chemiosmotic theory 
establishes the mechanism of energy 
transformation and coupling in oxidative 
phosphorylation. The unifying concept of 
the protonmotive force provides the 
framework for developing a consistent 
theoretical foundation of mitochondrial 
physiology and bioenergetics. We follow 
guidelines of the International Union of 
Pure and Applied Chemistry (IUPAC) on 
terminology in physical chemistry, 
extended by considerations of open 
systems and thermodynamics of 
irreversible processes. The concept-
driven constructive terminology 
incorporates the meaning of each 
quantity and aligns concepts and symbols 
with the nomenclature of classical 
bioenergetics. We endeavour to provide a 
balanced view of mitochondrial 
respiratory control and a critical 
discussion on reporting data of 
mitochondrial respiration in terms of 
metabolic flows and fluxes. Uniform 
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standards for evaluation of respiratory 
states and rates will ultimately contribute 
to reproducibility between laboratories 
and thus support the development of 
databases of mitochondrial respiratory 
function in species, tissues, and cells. 
Clarity of concept and consistency of 
nomenclature facilitate effective 
transdisciplinary communication, 
education, and ultimately further 
discovery. 
 
Keywords: Mitochondrial respiratory 
control, coupling control, mitochondrial 
preparations, protonmotive force, 
uncoupling, oxidative phosphorylation: 
OXPHOS, efficiency, electron transfer: ET, 
electron transfer system: ETS, proton leak, 
ion leak and slip compensatory state: LEAK, 
residual oxygen consumption: ROX, State 2, 
State 3, State 4, normalization, flow, flux, 
oxygen: O2 
 
Executive summary 
 
In view of the broad implications for health 
care, mitochondrial researchers face an 
increasing responsibility to disseminate 
their fundamental knowledge and novel 
discoveries to a wide range of stakeholders 
and scientists beyond the group of 
specialists. This requires implementation of 
a commonly accepted terminology within 
the discipline and standardization in the 
translational context. Authors, reviewers, 
journal editors, and lecturers are challenged 
to collaborate with the aim to harmonize the 
nomenclature in the growing field of 
mitochondrial physiology and bioenergetics, 
from evolutionary biology and comparative 
physiology to mitochondrial medicine. In the 
present communication we focus on the 
following concepts in mitochondrial 
physiology: 
 
1. Aerobic respiration is the O2 flux in 
catabolic reactions coupled to 
phosphorylation of ADP to ATP, and O2 flux 
in a variety of O2 consuming reactions apart 
from oxidative phosphorylation (OXPHOS). 
Coupling in OXPHOS is mediated by the 
translocation of protons across the 
mitochondrial inner membrane (mtIM) 
through proton pumps generating or 
utilizing the protonmotive force that is 
maintained between the mitochondrial 
matrix and intermembrane compartment or 
outer mitochondrial space. Compartmental 
coupling depends on ion translocation 
across a semipermeable membrane, which is 
defined as vectorial metabolism and 
distinguishes OXPHOS from cytosolic 
fermentation as counterparts of cellular core 
energy metabolism (Overview). Cell 
respiration is thus distinguished from 
fermentation: (1) Electron acceptors are 
supplied by external respiration for the 
maintenance of redox balance, whereas 
fermentation is characterized by an internal 
electron acceptor produced in intermediary 
metabolism. In aerobic cell respiration, 
redox balance is maintained by O2 as the 
electron acceptor. (2) Compartmental 
coupling in vectorial OXPHOS contrasts to 
exclusively scalar substrate-level 
phosphorylation in fermentation. 
 
2. When measuring mitochondrial 
metabolism, the contribution of 
fermentation and other cytosolic 
interactions must be excluded from analysis 
by disrupting the barrier function of the 
plasma membrane. Selective removal or 
permeabilization of the plasma membrane 
yields mitochondrial preparations—
including isolated mitochondria, tissue and 
cellular preparations—with structural and 
functional integrity. Subsequently, 
extramitochondrial concentrations of fuel 
substrates, ADP, ATP, inorganic phosphate, 
and cations including H+ can be controlled to 
determine mitochondrial function under a 
set of conditions defined as coupling control 
states. We strive to incorporate an easily 
recognized and understood concept-driven 
terminology of bioenergetics with explicit 
terms and symbols that define the nature of 
respiratory states. 
 
3. Mitochondrial coupling states are defined 
according to the control of respiratory 
oxygen flux by the protonmotive force, pmF, 
in an interaction of the electron transfer 
system generating the pmF and the 
phosphorylation system utilizing the pmF. 
Capacities of OXPHOS and electron transfer 
are measured at kinetically-saturating 
concentrations of fuel substrates, ADP and 
inorganic phosphate, and O2, or at optimal 
uncoupler concentrations, respectively, in 
the absence of Complex IV inhibitors such as 
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NO, CO, or H2S. Respiratory capacity is a 
measure of the upper boundary of the rate of 
respiration; it depends on the substrate type 
undergoing oxidation in a mitochondrial 
pathway, and provides reference values for 
the diagnosis of health and disease. 
Evaluation of the impact of evolutionary 
background, age, gender and sex, lifestyle 
and environment represents a major 
challenge for mitochondrial respiratory 
physiology and pathology. 
 
4. Incomplete tightness of coupling, i.e., 
some degree of uncoupling relative to the 
mitochondrial pathway-dependent coupling 
stoichiometry, is a characteristic of energy-
transformations across membranes. 
Uncoupling is caused by a variety of 
physiological, pathological, toxicological, 
pharmacological and environmental 
conditions that exert an influence not only on 
the proton leak and cation cycling, but also 
on proton slip within the proton pumps and 
the structural integrity of the mitochondria. 
A more loosely coupled state is induced by 
stimulation of mitochondrial superoxide 
formation and the bypass of proton pumps. 
In addition, the use of protonophores 
represents an experimental uncoupling 
intervention to assess the transition from a 
well-coupled to a noncoupled state of 
mitochondrial respiration. 
 
5. Respiratory oxygen consumption rates 
have to be carefully normalized to enable 
meta-analytic studies beyond the question of 
a particular experiment. Therefore, all raw 
data on rates and variables for normalization 
should be published in an open access data 
repository. Normalization of rates for: (1) 
the number of objects (cells, organisms); (2) 
the volume or mass of the experimental 
sample; and (3) the concentration of 
mitochondrial markers in the instrumental 
chamber are sample-specific normalizations, 
which are distinguished from system-
specific normalization for the volume of the 
instrumental chamber (the measuring 
system). 
 
6. The consistent use of terms and symbols 
facilitates transdisciplinary communication 
and will support the further development of 
a collaborative database on bioenergetics 
and mitochondrial physiology. 
 
Box 1: In brief – Mitochondria and 
Bioblasts 
‘For the physiologist, mitochondria 
afforded the first opportunity for an 
experimental approach to structure-
function relationships, in particular those 
involved in active transport, vectorial 
metabolism, and metabolic control 
mechanisms on a subcellular level’ 
(Ernster and Schatz 1981). 
 
Mitochondria are oxygen-consuming 
electrochemical generators (Figure 1). They 
evolved from the endosymbiotic 
alphaproteobacteria which became 
integrated into a host cell related to Asgard 
Archaea (Margulis 1970; Lane 2005; Roger 
et al 2017). Richard Altmann (1894) 
described the ‘bioblasts’, which include not 
only mitochondria as presently defined, but 
also symbiotic and free-living bacteria. The 
word ‘mitochondria’ (Greek mitos: thread; 
chondros: granule) was introduced by Carl 
Benda (1898). Mitochondrion is singular and 
mitochondria is plural. Abbreviation: mt, as 
generally used in mtDNA. 
 Contrary to current textbook dogma, 
which describes mitochondria as individual 
organelles, mitochondria form dynamic 
networks within eukaryotic cells. 
Mitochondrial movement is supported by 
microtubules. Mitochondrial size and 
number can change in response to energy 
requirements of the cell via processes known 
as fusion and fission; these interactions 
allow mitochondria to communicate within a 
network (Chan 2006). Mitochondria can 
even traverse cell boundaries in a process 
known as horizontal mitochondrial transfer 
(Torralba et al 2016). Another defining 
morphological characteristic of 
mitochondria is the double membrane. The 
mitochondrial inner membrane (mtIM) 
forms dynamic tubular to disk-shaped 
cristae that separate the mitochondrial 
matrix, i.e., the negatively charged internal 
mitochondrial compartment, from the 
intermembrane space; the latter being 
enclosed by the mitochondrial outer 
membrane (mtOM) and positively charged 
with respect to the matrix.  
 Intracellular stress factors may cause 
shrinking or swelling of the mitochondrial 
matrix that can ultimately result in 
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permeability transition (mtPT; Lemasters et 
al 1998). The mtIM contains the non-bilayer 
phospholipid cardiolipin, which is also 
involved in the mtOM (Gebert et al 2009) but 
is not present in any other eukaryotic 
cellular membrane. Cardiolipin has many 
regulatory functions (Oemer et al 2018); it 
promotes and stabilizes the formation of 
supercomplexes (SCInIIInIVn) based on 
dynamic interactions between specific 
respiratory complexes (McKenzie et al 2006; 
Greggio et al 2017; Lenaz et al 2017), and it 
supports proton transfer on the mtIM from 
the electron transfer system to F1FO-ATPase 
(ATP synthase; Yoshinaga et al 2016). The 
mtIM is plastic and exerts an influence on the 
functional properties of incorporated 
proteins (Waczulikova et al 2007).  
 Mitochondria constitute the structural 
and functional elementary components of 
cell respiration. Aerobic respiration is the 
reduction of molecular oxygen by electron 
transfer coupled to electrochemical proton 
translocation across the mtIM. In the process 
of OXPHOS, the catabolic reaction of oxygen 
consumption is electrochemically coupled to 
the transformation of energy in the 
phosphorylation of ADP to adenosine 
triphosphate (ATP; Mitchell 1961, 2011). 
Mitochondria are the powerhouses of the cell 
that contain the machinery of the OXPHOS-
pathways, including transmembrane 
respiratory complexes (proton pumps with 
FMN, Fe-S and cytochrome b, c, aa3 redox 
systems); alternative dehydrogenases and 
oxidases; the coenzyme ubiquinone (Q); 
F1FO-ATPase or ATP synthase; the enzymes 
of the tricarboxylic acid cycle (TCA), fatty 
acid and amino acid oxidation; transporters 
of ions, metabolites and co-factors; 
iron/sulphur cluster synthesis; and 
mitochondrial kinases related to catabolic 
pathways. TCA cycle intermediates are vital 
precursors for macromolecule biosynthesis 
(Diebold et al 2019). The mitochondrial 
proteome comprises over 1,200 types of 
protein (Calvo et al 2015; 2017), mostly 
encoded by nuclear DNA (nDNA), with a 
variety of functions, many of which are 
relatively well known, e.g., proteins 
regulating mitochondrial biogenesis or 
apoptosis, while others are still under 
investigation, or need to be identified, e.g., 
mtPT pore and alanine transporter. The 
mammalian mitochondrial proteome can be 
used to discover and characterize the genetic 
basis of mitochondrial diseases (Williams et 
al 2016; Palmfeldt and Bross 2017). 
 Numerous cellular processes are 
orchestrated by a constant crosstalk 
between mitochondria and other cellular 
components. For example, the crosstalk 
between mitochondria and the endoplasmic 
reticulum is involved in the regulation of 
calcium homeostasis, cell division, 
autophagy, differentiation, and anti-viral 
signaling (Murley and Nunnari 2016). 
Mitochondria contribute to the formation of 
peroxisomes, which are hybrids of 
mitochondrial and ER-derived precursors 
(Sugiura et al 2017). Cellular mitochondrial 
homeostasis (mitostasis) is maintained 
through regulation at transcriptional, post-
translational and epigenetic levels (Ling and 
Rönn 2018; Lisowski et al 2018), resulting in 
dynamic regulation of mitochondrial 
turnover by biogenesis of new mitochondria 
and removal of damaged mitochondria by 
fusion, fission and mitophagy (Singh et al 
2018). Cell signalling modules contribute to 
homeostatic regulation throughout the cell 
cycle or even cell death by activating 
proteostatic modules, e.g., the ubiquitin-
proteasome and autophagy-
lysosome/vacuole pathways; specific 
proteases like LON, and genome stability 
modules in response to varying energy 
demands and stress cues (Quiros et al 2016). 
In addition, several post-translational 
modifications, including acetylation and 
nitrosylation, are capable of influencing the 
bioenergetic response, with clinically 
significant implications for health and 
disease (Carrico et al 2018). 
 Mitochondria of higher eukaryotes 
typically maintain several copies of their 
own circular genome known as 
mitochondrial DNA (mtDNA; hundred to 
thousands per cell; Cummins 1998), which is 
maternally inherited in many species. 
However, biparental mitochondrial 
inheritance is documented in some 
exceptional cases in humans (Luo et al 
2018), is widespread in birds, fish, reptiles 
and invertebrate groups, and is even the 
norm in some bivalve taxonomic groups 
(Breton et al 2007; White et al 2008). The 
mitochondrial genome of the angiosperm  
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Amborella contains a record of six 
mitochondrial genome equivalents acquired 
by horizontal transfer of entire genomes, two 
from angiosperms, three from algae and one 
from mosses (Rice et al 2016). In unicellular 
organisms, i.e., protists, the structural 
organization of mitochondrial genomes is 
highly variable and includes circular and 
linear DNA (Zikova et al 2016). While some 
of the free-living flagellates exhibit the 
largest known gene coding capacity, e.g., 
jakobid Andalucia godoyi mtDNA codes for 
106 genes (Burger et al 2013), some protist 
groups, e.g., alveolates, possess 
mitochondrial genomes with only three 
protein-coding genes and two rRNAs (Feagin 
et al 2012). The complete loss of 
mitochondrial genome is observed in the 
highly reduced mitochondria of 
Cryptosporidium species (Liu et al 2016). 
Reaching the final extreme, the microbial 
eukaryote, oxymonad Monocercomonoides, 
has no mitochondrion whatsoever and lacks 
all typical nuclear-encoded mitochondrial 
proteins, showing that while in 99 % of 
organisms mitochondria play a vital role, this 
organelle is not indispensable (Karnkowska 
et al 2016). 
 In vertebrates, but not all invertebrates, 
mtDNA is compact (16.5 kB in humans) and 
encodes 13 protein subunits of the 
transmembrane respiratory Complexes CI, 
CIII, CIV and ATP synthase (F1FO-ATPase), 22 
tRNAs, and two ribosomal RNAs. Additional 
gene content has been suggested to include 
microRNAs, piRNA, smithRNAs, repeat 
associated RNA, long noncoding RNAs, and 
even additional proteins or peptides 
(Rackham et al 2011; Duarte et al 2014; Lee 
et al 2015; Cobb et al 2016). The 
mitochondrial genome requires nuclear-
encoded mitochondrially targeted proteins, 
e.g., TFAM, for its maintenance and 
expression (Rackham et al 2012). The 
Figure 1. Cell respiration and oxidative phosphorylation (OXPHOS) 
Mitochondrial respiration is the oxidation of fuel substrates (electron donors) with electron 
transfer to O2 as the electron acceptor. For explanation of symbols see also Overview.  
 (a) Respiration of living cells: Extramitochondrial catabolism of macrofuels and uptake of 
small molecules by the cell provide the mitochondrial fuel substrates. Dashed arrows indicate 
the connection between the redox proton pumps (respiratory Complexes CI, CIII and CIV) and 
the transmembrane protonmotive force, pmF. Coenzyme Q (Q) and the cytochromes b, c, and 
aa3 are redox systems of the mitochondrial inner membrane, mtIM. Glycerol-3-phosphate, Gp. 
 (b) Respiration in mitochondrial preparations: The mitochondrial electron transfer system 
(ETS) is (1) fuelled by diffusion and transport of substrates across the mtOM and mtIM, and in 
addition consists of the (2) matrix-ETS, and (3) membrane-ETS. Electron transfer converges at 
the N-junction, and from CI, CII and electron transferring flavoprotein complex (CETF) at the 
Q-junction. Unlabeled arrows converging at the Q-junction indicate additional ETS-sections 
with electron entry into Q through glycerophosphate dehydrogenase, dihydroorotate 
dehydrogenase, proline dehydrogenase, choline dehydrogenase, and sulfide-ubiquinone 
oxidoreductase. The dotted arrow indicates the branched pathway of oxygen consumption by 
alternative quinol oxidase (AOX). ET-pathways are coupled to the phosphorylation-pathway. 
The H+pos/O2 ratio is the outward proton flux from the matrix space to the positively (pos) 
charged vesicular compartment, divided by catabolic O2 flux in the NADH-pathway. The 
H+neg/P» ratio is the inward proton flux from the inter-membrane space to the negatively (neg) 
charged matrix space, divided by the flux of phosphorylation of ADP to ATP. These 
stoichiometries are not fixed because of ion leaks and proton slip. Modified from Lemieux et al 
(2017) and Rich (2013). 
 (c) OXPHOS-coupling: The H+ circuit couples O2 flux through the catabolic ET-
pathway, JkO2, to flux through the phosphorylation-pathway of ADP to ATP, JP». 
 (d) Phosphorylation-pathway catalyzed by the proton pump F1FO-ATPase (ATP synthase), 
adenine nucleotide translocase (ANT), and inorganic phosphate carrier (PiC). The H+neg/P» 
stoichiometry is the sum of the coupling stoichiometry in the F1FO-ATPase reaction (-2.7 H+pos 
from the positive intermembrane space, 2.7 H+neg to the matrix, i.e., the negative compartment) 
and the proton balance in the translocation of ADP3-, ATP4- and Pi2- (negative for substrates). 
Modified from Gnaiger (2020). 
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nuclear and the mitochondrial genomes 
encode peptides of the membrane spanning 
redox pumps (CI, CIII and CIV) and F1FO-
ATPase, leading to strong constraints in the 
coevolution of both genomes (Blier et al 
2001). 
 Given the multiple roles of mitochondria, 
it is perhaps not surprising that 
mitochondrial dysfunction is associated with 
a wide variety of genetic and degenerative 
diseases. Robust mitochondrial function is 
supported by physical exercise and caloric 
balance, and is central for sustained 
metabolic health throughout life. Therefore, 
a more consistent set of definitions for 
mitochondrial physiology will increase our 
understanding of the etiology of disease and 
improve the diagnostic repertoire of 
mitochondrial medicine with a focus on 
protective medicine, evolution, lifestyle, 
environment, and healthy aging. 
 
 
 
1. Introduction 
 
Mitochondria are the powerhouses of the cell 
with numerous morphological, 
physiological, molecular, and genetic 
functions (Box 1). Every study of 
mitochondrial health and disease faces 
Evolution, Age, Gender and sex, Lifestyle, 
and Environment (MitoEAGLE) as essential 
background conditions intrinsic to the 
individual person or cohort, species, tissue 
and to some extent even cell line. As a large 
and coordinated group of laboratories and 
researchers, the mission of the global 
MitoEAGLE Network is to generate the 
necessary scale, type, and quality of 
consistent data sets and conditions to 
address this intrinsic complexity. 
Harmonization of experimental protocols 
and implementation of a quality control and 
data management system are required to 
interrelate results gathered across a 
spectrum of studies and to generate a 
rigorously monitored database focused on 
mitochondrial respiratory function. In this 
way, researchers from a variety of 
disciplines can compare their findings using 
clearly defined and accepted international 
standards. 
 With an emphasis on quality of research, 
published data can be useful far beyond the 
specific question of a particular experiment. 
For example, collaborative data sets support 
the development of open-access databases 
such as those for National Institutes of 
Health sponsored research in genetics, 
proteomics, and metabolomics. Indeed, 
enabling meta-analysis is the most economic 
way of providing robust answers to 
biological questions (Cooper et al 2009). 
However, the reproducibility of quantitative 
results depend on accurate measurements 
under strictly-defined conditions. Likewise, 
meaningful interpretation and comparability 
of experimental outcomes requires 
harmonization of protocols between 
research groups at different institutes. In 
addition to quality control, a conceptual 
framework is also required to standardise 
and harmonise terminology and 
methodology. Vague or ambiguous jargon 
can lead to confusion and may convert 
valuable signals to wasteful noise. For this 
reason, measured values must be expressed 
in standard units for each parameter used to 
define mitochondrial respiratory function. A 
consensus on fundamental nomenclature 
and conceptual coherence, however, are 
missing in the expanding field of 
mitochondrial physiology. To fill this gap, the 
present communication provides an in-
depth review on harmonization of 
nomenclature and definition of technical 
terms, which are essential to improve the 
awareness of the intricate meaning of 
current and past scientific vocabulary. This is 
important for documentation and 
integration into data repositories in general, 
and quantitative modelling in particular 
(Beard 2005).  
 In this review, we focus on coupling states 
and fluxes through metabolic pathways of 
aerobic energy transformation in 
mitochondrial preparations in the attempt to 
establish a conceptually-oriented 
nomenclature in bioenergetics and 
mitochondrial physiology in a series of 
communications, prepared in the frame of 
the EU COST Action MitoEAGLE open to 
global bottom-up input. 
 
2. Coupling states and rates in 
mitochondrial preparations 
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‘Every professional group develops its own 
technical jargon for talking about matters 
of critical concern ... People who know a 
word can share that idea with other 
members of their group, and a shared 
vocabulary is part of the glue that holds 
people together and allows them to create 
a shared culture’ (Miller 1991). 
 
2.1. Cellular and mitochondrial respiration 
 
2.1.1. Aerobic and anaerobic catabolism 
and ATP turnover: In respiration, electron 
transfer is coupled to the phosphorylation of 
ADP to ATP, with energy transformation 
mediated by the protonmotive force, pmF 
(Figure 2). Anabolic reactions are coupled to 
catabolism, both by ATP as the intermediary 
energy currency and by small organic 
precursor molecules as building blocks for 
biosynthesis (Diebold et al 2019). Glycolysis 
involves substrate-level phosphorylation of 
ADP to ATP in fermentation without 
utilization of O2, studied mainly in living cells 
and organisms. Many cellular fuel substrates 
are catabolized to acetyl-CoA or to 
glutamate, and further electron transfer 
reduces nicotinamide adenine dinucleotide 
to NADH or flavin adenine dinucleotide to 
FADH2. Subsequent mitochondrial electron 
transfer to O2 is coupled to proton 
translocation for the control of the 
protonmotive force and phosphorylation of 
ADP (Figure 1b and 1c). In 
contrast,extramitochondrial oxidation of 
fatty acids and amino acids proceeds 
partially in peroxisomes without coupling to 
ATP production: acyl-CoA oxidase catalyzes 
the oxidation of FADH2 with electron 
transfer to O2; amino acid oxidases oxidize 
flavin mononucleotide FMNH2 or FADH2 
(Figure 1a). 
 The plasma membrane separates the 
intracellular compartment including the 
cytosol, nucleus, and organelles from the 
extracellular environment. Cell membranes 
include the plasma membrane and 
organellar membranes. The plasma 
membrane consists of a lipid bilayer with 
embedded proteins and attached organic 
molecules that collectively control the 
selective permeability of ions, organic 
molecules, and particles across the cell 
boundary. The intact plasma membrane 
prevents the passage of many water-soluble 
mitochondrial substrates and inorganic 
ions—such as succinate, adenosine 
diphosphate (ADP) and inorganic phosphate 
(Pi) that must be precisely controlled at 
kinetically-saturating concentrations for the 
analysis of mitochondrial respiratory 
capacities (Figure 2). Respiratory capacities 
delineate, comparable to channel capacity in 
information theory (Schneider 2006), the 
upper boundary of the rate of O2 
consumption measured in defined 
respiratory states. The intact plasma 
membrane limits the scope of investigations 
into mitochondrial respiratory function in 
living cells, despite the activity of solute 
carriers, e.g., the sodium-dependent 
dicarboxylate transporter SLC13A3 and the 
sodium-dependent phosphate transporter 
SLC20A2, which transport specific 
metabolites across the plasma membrane of 
various cell types, and the availability of 
plasma membrane-permeable succinate 
(Ehinger et al 2016). These limitations are 
overcome by the use of mitochondrial 
preparations. 
 
2.1.2. Specification of biochemical dose: 
Substrates, uncouplers, inhibitors, and other 
chemical reagents are titrated to analyse 
cellular and mitochondrial function. Nominal 
concentrations of these substances are 
usually reported as initial amount of 
Figure 2. Four-compartment model of 
oxidative phosphorylation 
Respiratory states (ET, OXPHOS, LEAK; 
Table 1) and corresponding rates (E, P, L) are 
connected by the protonmotive force, pmF. (1) 
ET-capacity, E, is partitioned into (2) 
dissipative LEAK-respiration, L, when the 
Gibbs energy change of catabolic O2 flux is 
irreversibly lost, (3) net OXPHOS-capacity, P-
L, with partial conservation of the capacity to 
perform work, and (4) the ET-excess capacity, 
E-P. Modified from Gnaiger (2020). 
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substance concentration [mol∙L-1] in the 
incubation medium.  
 Kinetically-saturating conditions are 
evaluated by substrate kinetics to obtain the 
maximum reaction velocity or maximum 
pathway flux, in contrast to solubility-
saturated conditions. When aiming at the 
measurement of kinetically-saturated 
processes—such as OXPHOS-capacities—
the concentrations for substrates can be 
chosen according to half-saturating 
substrate concentrations, c50, for metabolic 
pathways, or the Michaelis constant, Km, for 
enzyme kinetics. In the case of hyperbolic 
kinetics, only 80 % of maximum respiratory 
capacity is obtained at a substrate 
concentration of four times the c50, whereas 
substrate concentrations of 5, 9, 19 and 49 
times the c50 are theoretically required for 
reaching 83 %, 90 %, 95 % or 98 % of the 
maximal rate (Gnaiger 2001).  
 Other reagents are chosen to inhibit or 
alter a particular process. The amount of 
these chemicals in an experimental 
incubation is selected to maximize effect, 
avoiding unacceptable off-target 
consequences that would adversely affect 
the data being sought. Specifying the amount 
of substance in an incubation as nominal 
concentration in the aqueous incubation 
medium can be ambiguous (Doskey et al 
2015), particularly for cations (TPP+; 
fluorescent dyes such as safranin, TMRM; 
Chowdhury et al 2015) and lipophilic 
substances (oligomycin, uncouplers, 
permeabilization agents; Doerrier et al 
2018), which accumulate in the 
mitochondrial matrix or on biological 
membranes, respectively. Generally, dose 
can be specified per unit of biological sample, 
i.e., (nominal moles of xenobiotic)/(number 
of cells) [mol∙cell-1] or, as appropriate, per 
mass of biological sample [mol∙kg-1]. This 
approach to specification of dose provides a 
scalable parameter that can be used to 
design experiments, help interpret a wide 
variety of experimental results, and provide 
absolute information that allows researchers 
worldwide to make the most use of 
published data (Doskey et al 2015). The 
duration of exposure adds the dimension of 
time in contact with a particular dose. 
2.2. Mitochondrial preparations 
 
Mitochondrial preparations are defined as 
either isolated mitochondria or tissue and 
cellular preparations in which the barrier 
function of the plasma membrane is 
disrupted. Since this entails the loss of cell 
viability, mitochondrial preparations are not 
studied in vivo. In contrast to isolated 
mitochondria and tissue homogenate 
preparations, mitochondria in 
permeabilized tissues and cells are in situ 
relative to the plasma membrane. When 
studying mitochondrial preparations, 
substrate-uncoupler-inhibitor-titration 
(SUIT) protocols are used to establish 
respiratory coupling control states (CCS) and 
pathway control states (PCS) that provide 
reference values for various output variables 
(Table 1). Physiological conditions in vivo 
deviate from these experimentally obtained 
states; this is because kinetically-saturating 
concentrations, e.g., of ADP, oxygen (O2; 
dioxygen) or fuel substrates, may not apply 
to physiological intracellular conditions. 
Further information is obtained in studies of 
kinetic responses to variations in fuel 
substrate concentrations, [ADP], or [O2] in 
the range between kinetically-saturating 
concentrations and anoxia (Gnaiger 2001). 
 The cholesterol content of the plasma 
membrane is high compared to 
mitochondrial membranes (Korn 1969). 
Therefore, mild detergents—such as 
digitonin and saponin—can be applied to 
selectively permeabilize the plasma 
membrane via interaction with cholesterol; 
this allows free exchange of organic 
molecules and inorganic ions between the 
cytosol and the immediate cell environment, 
while maintaining the integrity and 
localization of organelles, cytoskeleton, and 
the nucleus. Application of permeabilization 
agents (mild detergents or toxins) leads to 
washout of cytosolic marker enzymes—such 
as lactate dehydrogenase—and results in the 
complete loss of cell viability (tested by 
nuclear staining using plasma membrane-
impermeable dyes), while mitochondrial 
function remains intact (tested by 
cytochrome c stimulation of respiration). 
 Digitonin concentrations have to be 
optimized according to cell type, particularly 
since mitochondria from cancer cells contain  
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significantly higher contents of cholesterol in 
both membranes (Baggetto and Testa-
Perussini, 1990). For example, a dose of 
digitonin of 8 fmol∙cell-1 (10 pg∙cell-1; 10 
µg∙10-6 cells) is optimal for permeabilization 
of endothelial cells, and the concentration in 
the incubation medium has to be adjusted 
according to the cell concentration (Doerrier 
et al 2018). Respiration of isolated 
mitochondria remains unaltered after the 
addition of low concentrations of digitonin 
or saponin. In addition to mechanical cell 
disruption during homogenization of tissue, 
permeabilization agents may be applied to 
ensure permeabilization of all cells in tissue 
homogenates. 
 Suspensions of cells permeabilized in the 
respiration chamber and crude tissue 
homogenates contain all components of the 
cell at highly dilute concentrations. All 
mitochondria are retained in chemically-
permeabilized mitochondrial preparations 
and crude tissue homogenates. In the 
preparation of isolated mitochondria, 
however, the mitochondria are separated 
from other cell fractions and purified by 
differential centrifugation, entailing the loss 
of mitochondria at typical recoveries ranging 
from 30 % to 80 % of total mitochondrial 
content (Lai et al 2018). Using Percoll or 
sucrose density gradients to maximize the 
purity of isolated mitochondria may 
compromise the mitochondrial yield or 
structural and functional integrity. 
Therefore, mitochondrial isolation protocols 
need to be optimized according to each 
study. The term mitochondrial preparation 
neither includes living cells, nor 
submitochondrial particles and further 
fractionated mitochondrial components. 
 
2.3. Electron transfer pathways 
 
Mitochondrial electron transfer (ET) 
pathways are fuelled by diffusion and 
transport of substrates across the mtOM and 
mtIM. In addition, the mitochondrial 
electron transfer system (ETS) consists of 
the matrix-ETS and membrane-ETS (Figure 
1b). Upstream sections of ET-pathways 
converge at the NADH-junction (N-junction). 
NADH is mainly generated in the 
Table 1. Coupling states and rates, and residual oxygen consumption in mitochondrial 
preparations. Respiration- and phosphorylation-flux, JkO2 and JP», are rates, characteristic of a 
state in conjunction with the protonmotive force, pmF. Coupling states are established at 
kinetically-saturating concentrations of fuel substrates and O2. 
State Rate  JkO2  JP» pmF Inducing 
factors 
Limiting factors 
LEAK L low, cation 
leak-
dependent 
respiration  
0 max. back-flux of 
cations including 
proton leak, 
proton slip  
JP» = 0: (1) without ADP, 
L(n); (2) max. ATP/ADP 
ratio, L(T); or (3) inhibition 
of the phosphorylation-
pathway, L(Omy) 
OXPHOS P high, ADP-
stimulated 
respiration, 
OXPHOS-
capacity 
max. high  kinetically-
saturating [ADP] 
and [Pi] 
JP» by phosphorylation-
pathway capacity; or JkO2 by 
ET-capacity 
ET E max., 
noncoupled 
respiration,  
ET-capacity 
0 low  optimal external 
uncoupler 
concentration for 
max. JO2,E 
JkO2 by ET-capacity 
ROX Rox min., residual 
O2 
consumption 
0 0 JO2,Rox in non-ET-
pathway 
oxidation 
reactions 
inhibition of all ET-
pathways; or absence of fuel 
substrates 
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tricarboxylic acid (TCA) cycle and is oxidized 
by Complex I (CI), with further electron entry 
into the coenzyme Q-junction (Q-junction). 
Similarly, succinate is formed in the TCA 
cycle and oxidized by CII to fumarate. CII is 
part of both the TCA cycle and the ETS, and 
reduces FAD to FADH2 with further 
reduction of ubiquinone to ubiquinol 
downstream of the TCA cycle in the Q-
junction. Thus FADH2 is not a substrate but is 
the product of CII, in contrast to erroneous 
metabolic maps shown in many publications. 
β-oxidation of fatty acids (FA) supplies 
reducing equivalents via (1) FADH2 as the 
substrate of electron transferring 
flavoprotein complex (CETF); (2) acetyl-CoA 
generated by chain shortening; and (3) 
NADH generated via 3-hydroxyacyl-CoA 
dehydrogenases. The ATP yield depends on 
whether acetyl-CoA enters the TCA cycle, or 
is for example used in ketogenesis. 
 Selected mitochondrial catabolic 
pathways of electron transfer from the 
oxidation of fuel substrates to the reduction 
of O2 are stimulated by addition of fuel 
substrates to the mitochondrial respiration 
medium after depletion of endogenous 
substrates (Figure 1b). Substrate 
combinations and specific inhibitors of ET-
pathway enzymes are used to obtain defined 
pathway control states in mitochondrial 
preparations (Gnaiger 2020). 
 
2.4. Respiratory coupling control 
 
2.4.1. Coupling: Coupling of electron transfer 
(ET) to phosphorylation of ADP to ATP is 
mediated by vectorial translocation of protons 
across the mtIM. Proton pumps generate or 
utilize the electrochemical pmF (Figure 1). 
The pmF is the sum of two partial forces, the 
electric force (electric potential difference) and 
chemical force (proton chemical potential 
difference, related to ΔpH; Mitchell 1961, 
2011). The catabolic flux of scalar reactions is 
collectively measured as O2 flux, JkO2.  
 Thus mitochondria are elementary 
components of energy transformation. 
Energy is a conserved quantity and cannot be 
lost or produced in any internal process 
(First Law of Thermodynamics). Open and 
closed systems can gain or lose energy only 
by external fluxes—by exchange with the 
environment. Therefore, energy can neither 
be produced by mitochondria, nor is there 
any internal process without energy 
conservation. Exergy or Gibbs energy (‘free 
energy’) is the part of energy that can 
potentially be transformed into work under 
conditions of constant temperature and 
pressure. Coupling is the interaction of an 
exergonic process (spontaneous, negative 
exergy change) with an endergonic process 
(positive exergy change) in energy 
transformations which conserve part of the 
exergy change. Exergy is not completely 
conserved, however, except at the limit of 
100 % efficiency of energy transformation in 
a coupled process. The exergy or Gibbs 
energy change that is not conserved by 
copling is irreversibly lost or dissipated, and 
is accounted for as the entropy change of the 
surroundings and the system, multiplied by 
the temperature of the irreversible process. 
 Pathway control states (PCS) and 
coupling control states (CCS) are 
complementary, since mitochondrial 
preparations depend on (1) an exogenous 
supply of pathway-specific fuel substrates 
and oxygen, and (2) exogenous control of 
phosphorylation (Figure 1). 
 
2.4.2. Phosphorylation, P», and P»/O2 
ratio: Phosphorylation in the context of 
OXPHOS is defined as phosphorylation of 
ADP by Pi to form ATP. On the other hand, the 
term phosphorylation is used generally in 
many contexts, e.g., protein phosphorylation. 
This provides the argument for introducing a 
symbol more discriminating and specific 
than P as used in the P/O ratio (phosphate to 
atomic oxygen ratio), where P indicates 
phosphorylation of ADP to ATP or GDP to 
GTP (Figure 1): The symbol P» indicates the 
endergonic (uphill) direction of 
phosphorylation ADP→ATP, and likewise P« 
the corresponding exergonic (downhill) 
hydrolysis ATP→ADP. P» refers mainly to 
electrontransfer phosphorylation but may 
also involve substrate-level phosphorylation 
as part of the TCA cycle (succinyl-CoA ligase, 
phosphoglycerate kinase) and 
phosphorylation of ADP catalyzed by 
pyruvate kinase, and of GDP phosphorylated 
by phosphoenolpyruvate carboxykinase. 
Transphosphorylation is performed by 
adenylate kinase, creatine kinase (mtCK), 
hexokinase and nucleoside diphosphate 
 
 
BEC2020.1 doi:10.26124/bec:2020-0001.vTest05  
www.bioenergetics-communications.org 13 of 44 
 
kinase. In isolated mammalian mitochondria, 
ATP production catalyzed by adenylate 
kinase (2 ADP ↔ ATP + AMP) proceeds 
without fuel substrates in the presence of 
ADP (Komlódi and Tretter 2017). Kinase 
cycles are involved in intracellular energy 
transfer and signal transduction for 
regulation of energy flux.The P»/O2 ratio 
(P»/4 e-) is two times the ‘P/O’ ratio (P»/2 
e-). P»/O2 is a generalized symbol, not 
specific for reporting Pi consumption (Pi/O2 
flux ratio), ADP depletion (ADP/O2 flux 
ratio), or ATP production (ATP/O2 flux 
ratio). The mechanistic P»/O2 ratio—or 
P»/O2 stoichiometry—is calculated from the 
proton–to–O2 and proton–to–
phosphorylation coupling stoichiometries 
(Figure 1c): 
 
 P»/O2  =   
Hpos
+ /O2
Hneg
+ /P»
 (1) 
 
The H+pos/O2 coupling stoichiometry 
(referring to the full four electron reduction 
of O2) depends on the relative involvement of 
the three coupling sites (respiratory 
Complexes CI, CIII and CIV) in the catabolic 
ET-pathway from reduced fuel substrates 
(electron donors) to the reduction of O2 
(electron acceptor). This varies with: (1) a 
bypass of CI by single or multiple electron 
input into the Q-junction; and (2) a bypass of 
CIV by involvement of alternative oxidases, 
AOX. AOX are expressed in all plants, some 
fungi, many protists, and several animal 
phyla, but are not expressed in vertebrate 
mitochondria (McDonald et al 2009). 
 The H+pos/O2 coupling stoichiometry 
equals 12 in the ET-pathways involving CIII 
and CIV as proton pumps, increasing to 20 
for the NADH-pathway through CI (Figure 
1b). A general consensus on H+pos/O2 
stoichiometries, however, remains to be 
reached (Hinkle 2005; Wikström and 
Hummer 2012; Sazanov 2015). The H+neg/P» 
coupling stoichiometry (3.7; Figure 1b) is 
the sum of 2.7 H+neg required by the F1FO-
ATPase of vertebrate and most invertebrate 
species (Watt et al 2010) and the proton 
balance in the translocation of ADP, ATP and 
Pi (Figure 1c). Taken together, the 
mechanistic P»/O2 ratio is calculated at 5.4 
and 3.3 for the N- and S-pathway, 
respectively (Eq. 1). The corresponding 
classical P»/O ratios (referring to the 2 
electron reduction of 0.5 O2) are 2.7 and 1.6 
(Watt et al 2010), in agreement with the 
measured P»/O ratio for succinate of 1.58 ± 
0.02 (Gnaiger et al 2000). 
 
2.4.3. Uncoupling: The effective P»/O2 flux 
ratio (YP»/O2 = JP»/JkO2) is diminished relative 
to the mechanistic P»/O2 ratio by intrinsic 
and extrinsic uncoupling or dyscoupling 
(Figure 3). This is distinct from switching 
between mitochondrial pathways that 
involve fewer than three proton pumps 
(‘coupling sites’: Complexes CI, CIII and CIV), 
bypassing CI through multiple electron 
entries into the Q-junction, or bypassing CIII 
and CIV through AOX (Figure 1b). 
Reprogramming of mitochondrial pathways 
leading to different types of substrates being 
oxidized may be considered as a switch of 
gears (changing the stoichiometry by 
altering the substrate that is oxidized) rather 
than uncoupling (loosening the tightness of 
coupling relative to a fixed stoichiometry). In 
addition, YP»/O2 depends on several 
experimental conditions of flux control, 
increasing as a hyperbolic function of [ADP] 
to a maximum value (Gnaiger 2001).
 Uncoupling of mitochondrial 
respiration is a general term comprising 
diverse mechanisms (Figure 3): 
 
1.  Proton leak across the mtIM from the 
positive to the negative compartment (H+ 
leak-uncoupled); 
2.  Cycling of other cations, strongly 
stimulated by mtPT; comparable to the 
use of protonophores, cation cycling is 
experimentally induced by valinomycin in 
the presence of K+ 
3.  Decoupling by proton slip in the redox 
proton pumps (CI, CIII and CIV) when 
protons are effectively not pumped in the 
ETS, or are not driving phosphorylation 
(F1FO-ATPase) 
4.  Loss of vesicular (compartmental) 
integrity when electron transfer is 
acoupled 
5.  Electron leak in the loosely coupled 
univalent reduction of O2 to superoxide 
(O2•­; superoxide anion radical) 
 
 Differences of terms—uncoupled vs. 
noncoupled—are easily overlooked, 
although they relate to different meanings of 
uncoupling (Table 2 and Figure 3). 
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2.5. Coupling states and respiratory rates 
 
To extend the classical nomenclature on 
mitochondrial coupling states (Section 2.6) 
by a concept-driven terminology that 
explicitly incorporates information on the 
meaning of respiratory states, the 
terminology must be general and not 
restricted to any particular experimental 
protocol or mitochondrial preparation 
(Gnaiger 2009). Diagnostically meaningful 
and reproducible conditions are defined for 
measuring mitochondrial function and 
respiratory capacities of core energy 
metabolism. Standard respiratory coupling 
states are obtained while maintaining a 
defined ET-pathway state with constant fuel 
substrates and inhibitors of specific 
branches of the ET-pathway. Concept-driven 
nomenclature aims at mapping the meaning 
and concept behind the words and acronyms 
onto the forms of words and acronyms 
(Miller 1991). The focus of concept-driven 
nomenclature is primarily the conceptual 
why, along with clarification of the 
experimental how (Table 1). 
 
LEAK: The contribution of intrinsically 
uncoupled O2 consumption is studied by 
preventing the stimulation of 
phosphorylation either in the absence of 
ADP or by inhibition of the 
phosphorylation-pathway. The 
corresponding states are collectively 
Table 2. Terms on respiratory coupling and uncoupling 
Term JkO2 P»/O2 Notes 
    
uncoupled L 0 non-phosphorylating LEAK-respiration (Fig. 2) 
proton leak- 
uncoupled 
 0 component of L, H+ diffusion across the mtIM (Fig. 
2b-d) 
inducibly 
uncoupled 
 0 by UCP1 or cation (e.g., Ca2+) cycling, strongly 
stimulated by permeability transition (mtPT); 
experimentally induced by valinomycin in the 
presence of K+ 
decoupled   0 component of L, proton slip when protons are 
effectively not pumped in the redox proton pumps 
CI, CIII and CIV or are not driving phosphorylation 
(F1FO-ATPase; Canton et al 1995) (Fig. 2b-d) 
loosely 
coupled 
 0 component of L, lower coupling due to superoxide 
formation and bypass of proton pumps by electron 
leak with univalent reduction of O2 to superoxide 
(O2•–; superoxide anion radical) 
dyscoupled   0 mitochondrial dysfunction due to pathologically, 
toxicologically, environmentally increased 
uncoupling 
noncoupled  E 0 ET-capacity, non-phosphorylating respiration 
stimulated to maximum flux at optimum exogenous 
protonophore concentration (Fig. 2d) 
well-coupled P high  OXPHOS-capacity, phosphorylating respiration 
with an intrinsic LEAK component (Fig. 2c) 
fully coupled P – L max. OXPHOS-capacity corrected for LEAK-respiration 
(Fig. 2a) 
acoupled   0 electron transfer in mitochondrial fragments 
without vectorial proton translocation upon loss of 
vesicular (compartmental) integrity 
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classified as LEAK-states when O2 
consumption compensates mainly for ion 
leaks, including the proton leak. 
OXPHOS: The ET- and phosphorylation-
pathways comprise coupled segments of 
the OXPHOS-system and provide 
reference values of respiratory capacities. 
The OXPHOS-capacity is measured at 
kinetically-saturating concentrations of 
ADP and Pi.  
ET: Compared to OXPHOS-capacity, the 
oxidative ET-capacity reveals the 
limitation of OXPHOS-capacity mediated 
by the phosphorylation-pathway. By 
application of external uncouplers, ET-
capacity is measured as noncoupled 
respirationThe three coupling states, 
LEAK, OXPHOS, and ET are shown 
schematically with the corresponding 
respiratory rates, abbreviated as L, P, and 
E, respectively (Figure 2). We distinguish 
between metabolic pathways and 
metabolic states with the corresponding 
metabolic rates; for example: ET-
pathways, ET-states, and ET-capacities, E, 
respectively (Table 1). The protonmotive 
force, pmF, is maximum in the LEAK-state 
of coupled mitochondria, driven by LEAK-
respiration at a minimum back-flux of 
cations to the matrix side, high in the 
OXPHOS-state when it drives 
phosphorylation, and very low in the ET-
state when uncouplers short-circuit the 
proton cycle (Table 1). 
 
2.5.1. LEAK-state (Figure 4a): The LEAK-
state is defined as a state of mitochondrial 
respiration when O2 flux mainly 
compensates for ion leaks in the absence of 
ATP synthesis, at kinetically-saturating 
concentrations of O2 and respiratory fuel 
substrates. LEAK-respiration is measured to 
obtain an estimate of intrinsic uncoupling 
without addition of an experimental 
uncoupler: (1) in the absence of adenylates, 
i.e., AMP, ADP and ATP; (2) after depletion of 
Figure 3. Mechanisms of respiratory uncoupling 
An intact mitochondrial inner membrane, mtIM, is required for vectorial, compartmental 
coupling. Inducible uncoupling, e.g., by activation of UCP1, increases LEAK-respiration; 
experimentally noncoupled respiration provides an estimate of ET-capacity obtained by 
titration of protonophores stimulating respiration to maximum O2 flux. H+ leak-uncoupled, 
decoupled, and loosely coupled respiration are components of intrinsic uncoupling (Table 2). 
Pathological dysfunction may affect all types of uncoupling, including permeability transition 
(mtPT), causing intrinsically dyscoupled respiration. Similarly, toxicological and 
environmental stress factors can cause extrinsically dyscoupled respiration. ‘Acoupled’ 
respiration is the consequence of structural disruption with catalytic activity of non-
compartmental mitochondrial fragments. Reduced fuel substrates, red; oxidized products, ox. 
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ADP at a maximum ATP/ADP ratio; or (3) 
after inhibition of the phosphorylation-
pathway by inhibitors of F1FO-ATPase 
(oligomycin), or adenine nucleotide 
translocase (carboxyatractyloside). 
Adjustment of the nominal concentration of 
these inhibitors to the concentration of 
biological sample applied can minimize or 
avoid inhibitory side-effects exerted on ET-
capacity or even some dyscoupling. The 
chelator EGTA is added to mt-respiration 
media to bind free Ca2+, thus limiting cation 
cycling. The LEAK-rate is a function of 
respiratory state, hence it depends on (1) the 
barrier function of the mtIM (‘leakiness’), (2) 
the electrochemical potential differences 
and concentration differences across the 
mtIM, and (3) the H+/O2 ratio of the ET-
pathway (Figure 1b). 
• Proton leak and uncoupled 
respiration: The intrinsic proton leak is 
the uncoupled leak current of protons in 
which protons diffuse across the mtIM in 
the dissipative direction of the downhill 
protonmotive force without coupling to 
phosphorylation (Figure 4a). The proton 
leak flux depends non-linearly on the 
protonmotive force (Garlid et al 1989; 
Divakaruni and Brand 2011), which is a 
temperature-dependent property of the 
mtIM and may be enhanced due to 
possible contamination by free fatty acids. 
Inducible uncoupling mediated by 
uncoupling protein 1 (UCP1) is 
physiologically controlled, e.g., in brown 
adipose tissue. UCP1 is a member of the  
mitochondrial carrier family that is 
involved in the translocation of protons 
across the mtIM (Jezek et al 2018). 
Consequently, this short-circuit lowers 
the pmF and stimulates electron transfer, 
respiration, and heat dissipation in the 
absence of phosphorylation of ADP. 
• Cation cycling: There can be other cation 
contributors to leak current including 
Ca2+ and probably magnesium. Ca2+ influx 
is balanced by mitochondrial Na+/Ca2+ or 
H+/Ca2+ exchange, which is balanced by 
Na+/H+ or K+/H+ exchanges. This is 
another effective uncoupling mechanism 
different from proton leak (Table 2). 
• Proton slip and decoupled respiration: 
Proton slip is the decoupled process in 
which protons are only partially 
translocated by a redox proton pump of 
the ET-pathways and slip back to the 
original vesicular compartment. The 
proton leak is the dominant contributor 
to the overall leak current in mammalian 
mitochondria incubated under 
physiological conditions at 37 °C, whereas 
proton slip increases at lower 
experimental temperature (Canton et al 
1995). Proton slip can also happen in 
association with the F1FO-ATPase, in 
which the proton slips downhill across 
the pump to the matrix without 
contributing to ATP synthesis. In each 
case, proton slip is a property of the 
proton pump and increases with the 
pump turnover rate. 
• Electron leak and loosely coupled 
respiration: Superoxide production by 
the ETS leads to a bypass of redox proton 
pumps and correspondingly lower P»/O2 
ratio. This depends on the actual site of 
electron leak and the scavenging of 
superoxide by cytochrome c, whereby 
electrons may re-enter the ETS with 
proton translocation by CIV. 
• Dyscoupled respiration: Mitochondrial 
injuries may lead to dyscoupling as a 
pathological or toxicological cause of 
uncoupled respiration. Dyscoupling may 
involve any type of uncoupling 
mechanism, e.g., opening the mtPT pore. 
Dyscoupled respiration is distinguished 
from experimentally induced noncoupled 
respiration in the ET-state (Table 2). 
• Protonophore titration and 
noncoupled respiration: 
Protonophores are uncouplers which are 
titrated to obtain maximum noncoupled 
respiration as a measure of ET-capacity. 
• Loss of compartmental integrity and 
acoupled respiration: Electron transfer 
and catabolic O2 flux proceed without 
compartmental proton translocation in 
disrupted mitochondrial fragments. Such 
fragments are an artefact of 
mitochondrial isolation, and may not fully 
fuse to re-establish structurally intact 
mitochondria. Loss of mtIM integrity, 
therefore, is the cause of acoupled 
respiration, which is a nonvectorial 
dissipative process without control by the 
protonmotive force. 
 
 
BEC2020.1 doi:10.26124/bec:2020-0001.vTest05  
www.bioenergetics-communications.org 17 of 44 
 
2.5.2. OXPHOS-state (Figure 4b): The 
OXPHOS-state is defined as the respiratory 
state with kinetically-saturating 
concentrations of O2, respiratory and 
phosphorylation substrates, and absence of 
exogenous uncoupler, which provides an 
estimate of the maximal respiratory capacity 
in the OXPHOS-state for any given ET-
pathway state. Respiratory capacities at 
kinetically-saturating substrate 
concentrations provide reference values or 
upper limits of performance, aiming at the 
generation of data sets for comparative 
purposes. Physiological activities and effects 
of substrate kinetics can be evaluated 
relative to the OXPHOS-capacity. 
 As discussed previously, 0.2 mM ADP 
does not kinetically-saturate flux in isolated 
mitochondria (Gnaiger 2001; Puchowicz et 
al 2004); greater [ADP] is required, 
particularly in permeabilized muscle fibers 
and cardiomyocytes, to overcome limitations 
by intracellular diffusion and by the reduced 
conductance of the mtOM (Jepihhina et al 
2011; Illaste et al 2012; Simson et al 2016), 
either through interaction with tubulin 
(Rostovtseva et al 2008) or other 
intracellular structures (Birkedal et al 2014). 
In addition, kinetically-saturating ADP 
concentrations need to be evaluated under 
different experimental conditions such as 
temperature (Lemieux et al 2017) and with 
different animal models (Blier and Guderley 
1993). In permeabilized muscle fiber 
bundles of high respiratory capacity, the 
apparent Km for ADP increases up to 0.5 mM 
(Saks et al 1998), consistent with 
experimental evidence that >90 % kinetic 
saturation is reached only at >5 mM ADP 
(Pesta and Gnaiger 2012). Similar ADP 
concentrations are also required for accurate 
determination of OXPHOS-capacity in human 
clinical cancer samples and permeabilized 
cells (Klepinin et al 2016; Koit et al 2017). 2.5 
to 5 mM ADP is sufficient to obtain the actual 
OXPHOS-capacity in many types of 
permeabilized tissue and cell preparations, 
but experimental validation is required in 
each specific case. 
 
2.5.3. Electron transfer-state (Figure 4c): 
O2 flux determined in the ET-state yields an 
Figure 4. Respiratory coupling states 
 (a) LEAK-state and rate, L: Oxidation 
only, since phosphorylation is arrested, JP» 
= 0, and catabolic O2 flux, JkO2,L, is 
controlled mainly by the proton leak and 
slip, JmH+neg (motive, subscript m), at 
maximum protonmotive force (Figure 2). 
ATP may be hydrolyzed by ATPases, JP«; 
then phosphorylation must be blocked. 
 (b) OXPHOS-state and rate, P: 
Oxidation coupled to phosphorylation, JP», 
which is stimulated by kinetically-
saturating [ADP] and [Pi], supported by a 
high protonmotive force maintained by 
pumping of protons to the positive 
compartment, JmH+pos. O2 flux, JkO2,P, is 
well-coupled at a P»/O2 flux ratio of 
JP»,P∙JO2,P
-1. Extramitochondrial ATPases 
may recycle ATP, JP«.  
 (c) ET-state and rate, E: Oxidation 
only, since phosphorylation is zero, JP» = 0, 
at optimum exogenous uncoupler 
concentration when noncoupled respiration, 
JkO2,E, is maximum. The F1FO-ATPase may 
hydrolyze extramitochondrial ATP. 
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estimate of ET-capacity. The ET-state is 
defined as the noncoupled state with 
kinetically-saturating concentrations of O2, 
respiratory substrate and optimum 
exogenous uncoupler concentration for 
maximum O2 flux. Uncouplers are weak lipid-
soluble acids which function as 
protonophores. These disrupt the barrier 
function of the mtIM and thus short-circuit 
the protonmotive system, functioning like a 
clutch in a mechanical system. As a 
consequence of the nearly collapsed 
protonmotive force, the driving force is 
insufficient for phosphorylation, and JP» = 0. 
The most frequently used uncouplers are 
carbonyl cyanide m-chloro phenyl 
hydrazone (CCCP), carbonyl cyanide p-
trifluoromethoxyphenylhydrazone (FCCP), 
or dinitrophenol (DNP). Stepwise titration of 
uncouplers stimulates respiration up to or 
above the level of O2 consumption rates in 
the OXPHOS-state; respiration is inhibited, 
however, above optimum uncoupler 
concentrations (Mitchell 2011). Data 
obtained with a single dose of uncoupler 
must be evaluated with caution, particularly 
when a fixed uncoupler concentration is 
used in studies exploring a treatment or 
disease that may alter the mitochondrial 
content or mitochondrial sensitivity to 
inhibition by uncouplers. There is a need for 
new protonophoric uncouplers that drive 
maximal respiration across a broad dosing 
range and do not inhibit respiration at high 
concentrations (Kenwood et al 2013). The 
effect on ET-capacity of the reversed 
function of F1FO-ATPase (JP«; Figure 4c) can 
be evaluated in the presence and absence of 
extramitochondrial ATP. 
 
2.5.4. ROX state: The state of residual O2 
consumption, ROX, is not a coupling state, 
but is relevant to assess respiratory function 
(Overview). The rate of residual oxygen 
consumption, Rox, is defined as O2 
consumption due to oxidative reactions 
measured after inhibition of ET with 
rotenone, malonic acid and antimycin A. 
Cyanide and azide inhibit not only CIV but 
catalase and several peroxidases involved in 
Rox. High concentrations of antimycin A, but 
not rotenone or cyanide, inhibit peroxisomal 
acyl-CoA oxidase and D-amino acid oxidase 
(Vamecq et al 1987). Rox represents a 
baseline used to correct respiration 
measured in defined coupling control states. 
Rox-corrected L, P and E are not only lower 
than total fluxes, but also change the flux 
control ratios L/P and L/E. Rox is not 
necessarily equivalent to non-mitochondrial 
reduction of O2, considering O2-consuming 
reactions in mitochondria that are not 
related to ET—such as O2 consumption in 
reactions catalyzed by monoamine oxidases 
(type A and B), monooxygenases 
(cytochrome P450 monooxygenases), 
dioxygenases (trimethyllysine dioxygenase), 
and several hydoxylases. Isolated 
mitochondrial fractions, especially those 
obtained from liver, may be contaminated by 
peroxisomes, as shown by transmission 
electron microscopy. This fact makes the 
exact determination of mitochondrial O2 
consumption and mitochondria-associated 
generation of reactive oxygen species 
complicated (Schönfeld et al 2009; Speijer 
2016; Figure 1). The variability of ROX-
linked O2 consumption needs to be studied in 
relation to non-ET enzyme activities, 
availability of specific substrates, O2 
concentration, and electron leakage leading 
to the formation of reactive oxygen species. 
 
2.5.5. Quantitative relations: E may exceed 
or be equal to P. E > P is observed in many 
types of mitochondria, varying between 
species, tissues and cell types (Gnaiger 
2009). E-P is the ET-excess capacity pushing 
the phosphorylation-flux to the limit of its 
capacity for utilizing the protonmotive force 
(Figure 2). In addition, the magnitude of E-P 
depends on the tightness of respiratory 
coupling or degree of uncoupling, since an 
increase of L causes P to increase towards 
the limit of E (Lemieux et al 2011). The ET-
excess capacity, E-P, therefore, provides a 
sensitive diagnostic indicator of specific 
injuries of the phosphorylation-pathway, 
under conditions when E remains constant 
but P declines relative to controls. Substrate 
cocktails supporting simultaneous 
convergent electron transfer to the Q-
junction for reconstitution of TCA cycle 
function establish pathway control states 
with high ET-capacity, and consequently 
increase the sensitivity of the E-P assay. 
 E cannot theoretically be lower than P. E 
< P must be discounted as an artefact, which 
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may be caused experimentally by: (1) loss of 
oxidative capacity during the time course of 
the respirometric assay, since E is measured 
subsequently to P; (2) using insufficient 
uncoupler concentrations; (3) using high 
uncoupler concentrations which inhibit ET 
(Gnaiger 2008); (4) high oligomycin 
concentrations applied for measurement of L 
before titrations of uncoupler, when 
oligomycin exerts an inhibitory effect on E. 
On the other hand, the ET-excess capacity is 
overestimated if kinetically non-saturating 
[ADP] or [Pi] are used. See State 3 in the next 
section. 
 The net OXPHOS-capacity is calculated by 
subtracting L from P (Figure 2). The net 
P»/O2 equals P»/(P-L), wherein the 
dissipative LEAK component in the OXPHOS-
state may be overestimated. This can be 
avoided by measuring LEAK-respiration in a 
state when the protonmotive force is 
adjusted to its slightly lower value in the 
OXPHOS-state by titration of an ET-inhibitor 
(Divakaruni and Brand 2011). Any turnover-
dependent components of proton leak and 
slip, however, are underestimated under 
these conditions (Garlid et al 1993). In 
general, it is inappropriate to use the term 
ATP production or ATP turnover for the 
difference of O2 flux measured in the 
OXPHOS- and LEAK-states. P-L is the upper 
limit of OXPHOS-capacity that is freely 
available for ATP production (corrected for 
LEAK-respiration) and is fully coupled to 
phosphorylation with a maximum 
mechanistic stoichiometry (Figure 2). 
 LEAK-respiration and OXPHOS-capacity 
depend on (1) the tightness of coupling 
under the influence of the respiratory 
uncoupling mechanisms (Figure 3), and (2) 
the coupling stoichiometry, which varies as a 
function of the substrate type undergoing 
oxidation in ET-pathways with either two or 
three coupling sites (Figure 1b). When 
substrate cocktails are used supporting the 
convergent NADH- and succinate-pathways 
simultaneously, the relative contribution of 
ET-pathways with three or two coupling 
sites cannot be controlled experimentally, is 
difficult to determine, and may shift in 
transitions between LEAK-, OXPHOS- and 
ET-states (Gnaiger 2020). Under these 
experimental conditions, we cannot separate 
the tightness of coupling versus coupling 
stoichiometry as the mechanisms of 
respiratory control in a shift of L/P ratios. 
The tightness of coupling and fully coupled 
O2 flux, P-L (Table 2), therefore, are obtained 
from measurements of coupling control of 
LEAK-respiration, OXPHOS- and ET-
capacities in well-defined pathway states, 
using either pyruvate and malate as 
substrates or the classical succinate and 
rotenone substrate-inhibitor combination 
(Figure 1b). 
 
2.5.6. The steady-state: Mitochondria 
represent a thermodynamically open system 
in non-equilibrium states of biochemical 
energy transformation. State variables 
(protonmotive force; redox states) and 
metabolic rates (fluxes) are measured in 
defined mitochondrial respiratory states. 
Steady-states can be obtained only in open 
systems, in which changes by internal 
transformations, e.g., O2 consumption, are 
instantaneously compensated for by 
external fluxes across the system boundary, 
e.g., O2 supply, preventing a change of O2 
concentration in the system (Gnaiger 
1993b). Mitochondrial respiratory states 
monitored in closed systems satisfy the 
criteria of pseudo-steady states for limited 
periods of time, when changes in the system 
(concentrations of O2, fuel substrates, ADP, 
Pi, H+) do not exert significant effects on 
metabolic fluxes (respiration, 
phosphorylation). Such pseudo-steady states 
require respiratory media with sufficient 
buffering capacity and substrates 
maintained at kinetically-saturating 
concentrations, and thus depend on the 
kinetics of the processes under investigation. 
 
2.6. Classical terminology for isolated 
mitochondria 
‘When a code is familiar enough, it ceases 
appearing like a code; one forgets that 
there is a decoding mechanism. The 
message is identical with its meaning’ 
(Hofstadter 1979). 
 
Chance and Williams (1955; 1956) 
introduced five classical states of 
mitochondrial respiration and cytochrome 
redox states. Table 3 shows a protocol with 
isolated mitochondria in a closed 
respirometric chamber, defining a sequence 
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of respiratory states. States and rates are not 
distinguished in this nomenclature. 
 
2.6.1. State 1 is obtained after addition of 
isolated mitochondria to air-saturated 
isoosmotic/isotonic respiration medium 
containing Pi, but no fuel substrates and no 
adenylates. 
 
2.6.2. State 2 is induced by addition of a 
‘high’ concentration of ADP (typically 100 to 
300 µM), which stimulates respiration 
transiently on the basis of endogenous fuel 
substrates and phosphorylates only a small 
portion of the added ADP. State 2 is then 
obtained at a low respiratory activity limited 
by exhausted endogenous fuel substrate 
availability (Table 3). If addition of specific 
inhibitors of respiratory complexes such as 
rotenone does not cause a further decline of 
O2 flux, State 2 is equivalent to the ROX state 
(Table 1). Undefined endogenous fuel 
substrates are a confounding factor of 
pathway control, contributing to the effect of 
subsequently externally added substrates 
and inhibitors. In an alternative sequence of 
titration steps, the second state is induced by 
addition of fuel substrate without ADP or 
ATP (Estabrook 1967). In contrast to the 
original State 2 defined in Table 1 as a ROX 
state, the alternative ‘State 2’ is a LEAK-state 
with L(n). Some researchers have called this 
condition as ‘pseudostate 4’. 
 
2.6.3. State 3 is the state stimulated by 
addition of fuel substrates while the ADP 
concentration in the original State 2 is still 
high (Table 3) and supports coupled energy 
transformation. 'High ADP' is a 
concentration of ADP specifically selected to 
allow the measurement of State 3 to State 4 
transitions of isolated mitochondria in a 
closed respirometric chamber. Repeated 
ADP titration re-establishes State 3 at ‘high 
ADP’. Starting at O2 concentrations near air-
saturation (193 or 238 µM O2 at 37 °C or 25 
°C and sea level at 1 atm or 101.32 kPa, and 
an oxygen solubility of respiration medium 
at 0.92 times that of pure water; Forstner 
and Gnaiger 1983), the total ADP 
concentration added must be low enough 
(typically 100 to 300 µM) to allow 
phosphorylation to ATP at a coupled O2 flux 
that does not lead to O2 depletion during the 
transition to State 4. In contrast, kinetically-
saturating ADP concentrations usually are 
10-fold higher than 'high ADP', e.g., 2.5 mM in 
isolated mitochondria. The abbreviation 
State 3u is occasionally used in 
bioenergetics, to indicate the state of 
respiration after titration of an uncoupler, 
without sufficient emphasis on the 
fundamental difference between OXPHOS-
capacity (well-coupled with an endogenous 
uncoupled component) and ET-capacity 
(noncoupled). 
 
2.6.4. State 4 is a LEAK-state that is obtained 
only if the mitochondrial preparation is 
intact and well-coupled. Depletion of ADP by 
phosphorylation to ATP causes a decline of 
O2 flux in the transition from State 3 to State 
4. Under the conditions of State 4, a 
maximum protonmotive force and high 
ATP/ADP ratio are maintained. The gradual 
decline of YP»/O2 towards diminishing [ADP] 
at State 4 must be taken into account for 
calculation of P»/O2 ratios (Gnaiger 2001). 
State 4 respiration, L(T) (Table 1), reflects 
intrinsic proton leak and ATP hydrolysis 
activity. O2 flux in State 4 is an 
overestimation of LEAK-respiration if the 
contaminating ATP hydrolysis activity 
recycles some ATP to ADP, JP«, which 
stimulates respiration coupled to 
phosphorylation, JP» > 0. Some degree of 
Table 3. Metabolic states of mitochondria (Chance and 
Williams, 1956; Table V). 
 
State 
 
[O2] 
ADP 
level 
Substrate 
  level 
Respiration 
  rate 
Rate-limiting 
  substance 
1 >0 low   low   slow   ADP 
2 >0 high   ~0   slow   substrate 
3 >0 high   high   fast   respiratory chain 
4 >0 low   high   slow   ADP 
5 0 high   high   0   oxygen 
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mechanical disruption and loss of 
mitochondrial integrity allows the exposed 
mitochondrial F1FO-ATPases to hydrolyze 
the ATP synthesized by the fraction of 
coupled mitochondria. This can be tested by 
inhibition of the phosphorylation-pathway 
using oligomycin, ensuring that JP» = 0 (State 
4o). On the other hand, the State 4 
respiration reached after exhaustion of 
added ADP is a more physiological condition, 
i.e., presence of ATP, ADP and even AMP. 
Sequential ADP titrations re-establish State 
3, followed by State 3 to State 4 transitions 
while sufficient O2 is available. Anoxia may 
be reached, however, before exhaustion of 
ADP (State 5). 
 
2.6.5. State 5 ‘may be obtained by antimycin 
A treatment or by anaerobiosis’ (Chance and 
Williams, 1955). These definitions give State 
5 two different meanings: ROX or anoxia. 
Anoxia is obtained after exhaustion of O2 in a 
closed respirometric chamber. Diffusion of 
O2 from the surroundings into the aqueous 
solution may be a confounding factor 
preventing complete anoxia (Gnaiger 2001). 
 In Table 3, only States 3 and 4 are 
coupling control states, with the restriction 
that rates in State 3 may be limited 
kinetically by non-saturating ADP 
concentrations. 
 
2.7. Control and regulation 
 
The terms metabolic control and regulation 
are frequently used synonymously, but are 
distinguished in metabolic control analysis: 
“We could understand the regulation as the 
mechanism that occurs when a system 
maintains some variable constant over time, 
in spite of fluctuations in external conditions 
(homeostasis of the internal state). On the 
other hand, metabolic control is the power to 
change the state of the metabolism in 
response to an external signal” (Fell 1997). 
Respiratory control may be induced by 
experimental control signals that exert an 
influence on: (1) ATP demand and ADP 
phosphorylation-rate; (2) fuel substrate 
composition, pathway competition; (3) 
available amounts of substrates and O2, e.g., 
starvation and hypoxia; (4) the 
protonmotive force, redox states, flux–force 
relationships, coupling and efficiency; (5) 
Ca2+ and other ions including H+; (6) 
inhibitors, e.g., nitric oxide or intermediary 
metabolites such as oxaloacetate; (7) 
signalling pathways and regulatory proteins, 
e.g., insulin resistance, transcription factor 
hypoxia inducible factor 1.  
 Mechanisms of respiratory control and 
regulation include adjustments of: (1) 
enzyme activities by allosteric mechanisms 
and phosphorylation; (2) enzyme content, 
concentrations of cofactors and conserved 
moieties such as adenylates, nicotinamide 
adenine dinucleotide [NAD+/NADH], 
coenzyme Q, cytochrome c; (3) metabolic 
channeling by supercomplexes; and (4) 
mitochondrial density (enzyme 
concentrations) and morphology 
(membrane area, cristae folding, fission and 
fusion). Mitochondria are targeted directly 
by hormones, e.g., progesterone and 
glucacorticoids, which affect their energy 
metabolism (Lee et al 2013; Gerö and Szabo 
2016; Price and Dai 2016; Moreno et al 2017; 
Singh et al 2018). Evolutionary or acquired 
differences in the genetic and epigenetic 
basis of mitochondrial function (or 
dysfunction) between individuals; age; 
biological sex, and hormone concentrations; 
life style including exercise and nutrition; 
and environmental issues including thermal, 
atmospheric, toxic and pharmacological 
factors, exert an influence on all control 
mechanisms listed above. For reviews, see 
Brown 1992; Gnaiger 1993a, 2009; 2020; 
Paradies et al 2014; Morrow et al 2017. 
 Lack of control by a metabolic pathway, 
e.g., phosphorylation-pathway, means that 
there will be no response to a variable 
activating it, e.g., [ADP]. The reverse, 
however, is not true as the absence of a 
response to [ADP] does not exclude the 
phosphorylation-pathway from having some 
degree of control. The degree of control of a 
component of the OXPHOS-pathway on an 
output variable, such as O2 flux, will in 
general be different from the degree of 
control on other outputs, such as 
phosphorylation-flux or proton leak flux. 
Therefore, it is necessary to be specific as to 
which input and output are under 
consideration (Fell 1997). 
 Respiratory control refers to the ability of 
mitochondria to adjust O2 flux in response to 
external control signals by engaging various 
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mechanisms of control and regulation. 
Respiratory control is monitored in a 
mitochondrial preparation under conditions 
defined as respiratory states, preferentially 
under near-physiological conditions of 
temperature, pH, and medium ionic 
composition, to generate data of higher 
biological relevance. When phosphorylation 
of ADP to ATP is stimulated or depressed, an 
increase or decrease is observed in electron 
transfer measured as O2 flux in respiratory 
coupling states of intact mitochondria 
(‘controlled states’ in the classical 
terminology of bioenergetics). Alternatively, 
coupling of electron transfer with 
phosphorylation is diminished by 
uncouplers. The corresponding coupling 
control state is characterized by a high 
respiratory rate without control by P» 
(noncoupled or ‘uncontrolled state’). 
 
3. What is a rate? 
 
The term rate is not adequately defined to be 
useful for reporting data. Normalization of 
rates leads to a diversity of formats. 
Application of common and defined units is 
required for direct transfer of reported 
results into a data repository. The second [s] 
is the SI unit for the base quantity time. It is 
also the standard time-unit used in solution 
chemical kinetics. 
 The inconsistency of the meanings of rate 
becomes apparent when considering Galileo 
Galilei’s famous principle, that ‘bodies of 
different weight all fall at the same rate (have 
a constant acceleration)’ (Coopersmith 
2010). A rate may be an extensive quantity, 
which is a flow, I, when expressed per object 
(per number of cells or organisms) or per 
chamber (per instrumental system). System 
is defined as the open or closed chamber of 
the measuring device. A rate is a flux, J, when 
expressed as a size-specific quantity (Figure 
5A; Box 2). 
 
Box 2: Metabolic flows and fluxes: 
vectoral, vectorial, and scalar 
 
Flow is an extensive quantity (I; per system), 
distinguished from flux as a size-specific 
quantity (J; per system size). Flows, Itr, are 
defined for all transformations as extensive 
quantities. This is a generalization derived 
from electrical terms: Electric charge per 
unit time is electric flow or current, Iel = 
dQel∙dt-1 [A≡ C∙s-1]. When dividing Iel by size 
of the system (cross-sectional area of a 
‘wire’), we obtain flux as a size-specific 
quantity; this is the current density (surface-
density of flow) perpendicular to the 
direction of flux, Jel = Iel∙A-1 [A∙m-2] (Cohen et 
al 2008). Fluxes with spatial geometric 
direction and magnitude are vectors. Vector 
and scalar fluxes are related to flows as Jtr = 
Itr∙A-1 [mol∙s-1∙m-2] and Jtr = Itr∙V-1 
[mol∙s-1∙m-3], expressing flux as an area-
specific vector or volume-specific vectorial 
or scalar quantity, respectively (Gnaiger 
1993b). We use the metre–kilogram–
second–ampere (MKSA) international 
system of units (SI) for general cases ([m], 
[kg], [s] and [A]), with decimal SI prefixes for 
specific applications (Table 4). 
 We suggest defining: (1) vectoral fluxes, 
which are translocations as functions of 
gradients with direction in geometric space 
in continuous systems; (2) vectorial fluxes, 
which describe translocations in 
discontinuous systems and are restricted to 
information on compartmental differences 
(transmembrane proton flux); and (3) scalar 
fluxes, which are localized transformations 
without translocation, such as chemical 
reactions in a homogenous system (catabolic 
O2 flux, JkO2). 
 
• Extensive quantities: An extensive 
quantity increases proportionally with 
system size. For example, mass and 
volume are extensive quantities. Flow is 
an extensive quantity. The magnitude of 
an extensive quantity is completely 
additive for non-interacting subsystems. 
The magnitude of these quantities 
depends on the extent or size of the 
system (Cohen et al 2008).  
• Size-specific quantities: ‘The adjective 
specific before the name of an extensive 
quantity is often used to mean divided by 
mass’ (Cohen et al 2008). The term 
specific has different meanings in three 
particular contexts: (1) In the system-
paradigm, (a) mass-specific flux is flow 
divided by mass of the system (the mass 
of everything contained in the 
instrumental chamber or reactor). (b) 
Rates are frequently expressed as 
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volume-specific flux (volume of the 
instrumental chamber). A mass-specific 
or volume-specific quantity is 
independent of the extent of non-
interacting homogenous subsystems. (2) 
In the context of sample size, tissue-
specific quantities are related to the mass 
or volume of the sample in contrast to the 
mass or volume of the system (e.g., muscle 
mass-specific or cell volume-specific 
normalization; Figure 5). (3) An entirely 
different meaning is implied in the 
context of sample type (e.g., muscle-
specific compared to brain-specific 
properties). 
• Intensive quantities: In contrast to size-
specific properties, forces are intensive 
quantities defined as the change of an 
extensive quantity per advancement of an 
energy transformation (Gnaiger 1993b). 
• Formats: The  quantity of a sample X can 
be expressed in different formats. nX, NX, 
and mX are the molar amount, number, 
and mass of X, respectively. When 
different formats are indicated in symbols 
of derived quantities, the format (n, N, m) 
is shown as a subscript (underlined italic), 
such as in IO2/NX and JO2/mX. As of 2019 May 
20, the definition of the SI unit mole [mol] 
is based on a natural constant, namely 
Avogadro’s constant: one mole contains 
exactly 6.02214076∙1023 elementary 
entities, in contrast to the former 
definition in terms of the number of molar 
Figure 5. Flow and flux, and 
normalization in structure-
function analysis 
 (A) A fundamental distinction is 
made between metabolic rate 
related to the experimental sample 
(left) or to the instrumental chamber 
(right). The different meanings of 
rate need to be specified by the type 
of normalization. Left: Results are 
expressed as mass-specific flux, 
JmX, per mg protein, dry or wet 
mass. Cell volume, Vce, may be used 
for normalization (volume-specific 
flux, JVce). Normalization per 
mitochondrial elementary marker, 
mtE, relies on determination of mt-
markers expressed in various 
mitochondrial elementary units 
[mtEU]. Right: Flow per 
instrumental chamber, I, or flux per 
chamber volume, JV, are merely 
reported for methodological 
reasons.  
 (B) O2 flow per cell, IO2/Nce, is 
the product of mitochondria-
specific flux, mt-density and mass 
per cell. Unstructured analysis: 
performance is the product of mass-
specific flux, JO2/mce [mol∙s
-1∙kg-1], 
and size (mass per cell). Structured 
analysis: performance is the 
product of mitochondrial function 
(mt-specific flux) and structure 
(mt-content). Modified from 
Gnaiger (2020). For further details 
see Table 4. 
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   Table 4. Sample concentrations and normalization of flux. 
Expression Symbol Definition Unit Notes 
Sample     
identity of sample X object: cell, tissue, animal, 
patient 
  
number of sample entities X NX number of objects x  1 
mass of sample X mX  kg  2 
mass of object X mNX mNX = mX∙NX-1 kg∙x-1 2 
Mitochondria     
mitochondria  mt  X = mt   
amount of  
 mt-elementary marker 
 
mtE 
 
quantity of mt-marker 
 
mtEU 
 
Concentrations     
object number concentration CNX CNX = NX∙V-1  x∙m-3 3 
sample mass concentration CmX CmX = mX∙V-1  kg∙m-3  
mitochondrial concentration CmtE CmtE = mtE∙V-1  mtEU∙m-3 4 
specific mitochondrial density DmtE DmtE = mtE∙mX-1  mtEU∙kg-1 5 
mitochondrial content, 
 mtE per number of sample 
entities (objects) X 
 
mtENX 
 
mtENX = mtE∙NX-1 
 
mtEU∙x-1 
 
6 
O2 flow and flux    7 
flow, system IO2 internal flow mol∙s
-1 8 
volume-specific flux JV,O2 JV,O2 = IO2∙V
-1 mol∙s-1∙m-3 9 
flow per object X IO2/NX IO2/NX = JV,O2∙CNX
-1 mol∙s-1∙x-1 10 
mass-specific flux JO2/mX JO2/mX = JV,O2∙CmX
-1 mol∙s-1∙kg-1  
mt-marker-specific flux JO2/mtE JO2/mtE = JV,O2∙CmtE
-1 mol∙s-1∙mtEU-1 11 
1 The unit x for a number is not used by IUPAC. To avoid confusion, the units [kg∙x-1] and [kg] distinguish the mass per 
object from the mass of a sample that may contain any number of objects. Similarly, the units for flow per system versus 
flow per object are [mol∙s-1] (Note 8) and [mol∙s-1∙x-1] (Note 10). 
2 Units are given in the MKSA system (Box 2). The SI prefix k is used for the SI base unit of mass (kg = 1,000 g). In praxis, 
various SI prefixes are used for convenience, to make numbers easily readable, e.g., 1 mg tissue, cell or mitochondrial 
mass instead of 0.000001 kg. 
3 In case of cells (sample X = cells), the object number concentration is CNce = Nce∙V-1, and volume may be expressed in 
[dm3 ≡ L] or [cm3 = mL]. See Table 5 for different object types. 
4 mt-concentration is an experimental variable, dependent on sample concentration: (1) CmtE = mtE∙V-1; (2) CmtE = 
mtEX∙CNX; (3) CmtE = CmX∙DmtE. 
5 If the amount of mitochondria, mtE, is expressed as mitochondrial mass, then DmtE is the mass fraction of mitochondria 
in the sample. If mtE is expressed as mitochondrial volume, Vmt, and the mass of sample, mX, is replaced by volume of 
sample, VX, then DmtE is the volume fraction of mitochondria in the sample. 
6 mtENX = mtE∙NX-1 = CmtE∙CNX-1.  
7 O2 can be replaced by other chemicals to study different reactions, e.g., ATP, H2O2, or vesicular compartmental 
translocations, e.g., Ca2+. 
8 IO
2
 and V are defined per instrumental chamber as a system of constant volume (and constant temperature), which 
may be closed or open. IO
2
 is abbreviated for IrO
2
, i.e., the metabolic or internal O2 flow of the chemical reaction r in 
which O2 is consumed, hence the negative stoichiometric number, νO
2
 = -1. IrO
2
 = drnO
2
/dt∙νO
2
-1. If r includes all chemical 
reactions in which O2 participates, then drnO
2
 = dnO
2
 – denO
2
, where dnO
2
 is the change in the amount of O2 in the 
instrumental chamber and denO
2
 is the amount of O2 added externally to the system. At steady state, by definition dnO
2
 
= 0, hence drnO
2
 = –denO
2
. Note that in this context ‘external’, e, refers to the instrumental system, whereas in respiratory 
physiology ‘external’, ext, refers to the organism (Overview). 
9 JV,O
2
 is an experimental variable, expressed per volume of the instrumental chamber.  
10 IO
2
/NX is a physiological variable, depending on the size of entity X. 
11 There are many ways to normalize for a mitochondrial marker, that are used in different experimental approaches: 
(1) JO
2
/mtE = JV,O
2
∙CmtE-1; (2) JO
2
/mtE = JV,O
2
∙CmX-1∙DmtE-1 = JO
2
/mX∙DmtE-1; (3) JO
2
/mtE = JV,O
2
∙CNX-1∙mtENX-1 = IO
2
/NX∙mtENX-1; (4) JO
2
/mtE 
= IO
2
∙mtE-1. The mt-elementary unit [mtEU] varies depending on the mt-marker. 
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atoms in the mass of 0.012 kilogram of 
carbon 12 (Gibney 2018). Metabolic 
oxygen flow and flux are expressed in the 
format, nO2 [mol], but in the volume 
format, VO2 [m
3], in ergometry. These 
formats are distinguished as JnO2/mX and 
JVO2/mX, respectively, for mass-specific flux. 
Further examples are given in Table 4 
and Figure 5. 
 
 
4. Normalization of rate per sample 
 
The challenges of measuring mitochondrial 
respiratory flux are matched by those of 
normalization. Normalization (Table 4) is 
guided by physicochemical principles, 
methodological considerations, and 
conceptual strategies (Figure 5). 
 
4.1. Flow: per object 
 
4.1.1. Number concentration, CNX: 
Normalization per sample concentration is 
routinely required to report respiratory 
data. CNX is the experimental number 
concentration of sample X. In the case of 
animals NX is the number of organisms in the 
chamber, e.g., nematodes, CNX = NX∙V-1 [x∙L-1]. 
Similarly, the number of cells per chamber 
volume is the number concentration of cells, 
CNce = Nce∙V-1 [x∙L-1], where Nce is the number 
of cells in the chamber (Table 4). 
 
4.1.2. Flow per object, IO2/NX: O2 flow per 
cell is calculated from volume-specific O2 
flux, JV,O2 [nmol∙s
-1∙L-1] (per V of the 
instrumental chamber [L]), divided by the 
number concentration of cells. The total cell 
count is the sum of viable and dead cells, Nce 
= Nvce+Ndce (Table 5). The cell viability index, 
VI = Nvce∙Nce-1, is the ratio of the number of 
viable cells, Nvce, per total number of living 
cells in the population. After experimental 
permeabilization, all cells are permeabilized, 
Npce = Nce. The cell viability index can be used 
to normalize respiration for the number of 
cells that have been viable before 
experimental permeabilization, IO2/Nvce = 
IO2/Nce∙VI
-1, considering that mitochondrial 
respiratory dysfunction in dead cells should 
be eliminated as a confounding factor. 
 
4.2. Size-specific flux: per sample size 
 
4.2.1. Sample concentration, CmX: 
Considering permeabilized tissue, 
homogenate or cells as the sample, X, the 
sample mass is mX [mg], which is frequently 
measured as wet or dry mass, mw or md [mg], 
respectively, or as mass of protein, mProtein. The 
sample concentration is the mass of the 
subsample per volume of the instrumental 
chamber, CmX = mX∙V-1 [g∙L-1 = mg∙mL-1]. X is 
the type of sample—isolated mitochondria, 
tissue homogenate, permeabilized muscle fibers 
or cells (Table 4). mce [mg] is the total mass of 
all cells in an instrumental chamber, whereas 
mNce = mce∙Nce-1 [mg∙x-1] is the (average) mass of 
an individual cell (Table 5). 
 
4.2.2. Size-specific flux: Cellular O2 flow 
can be compared between cells of identical 
size. To take into account changes and 
differences in cell size (Renner et al 2003), 
normalization is required to obtain cell size-
specific or mitochondrial marker-specific O2 
flux (Figure 5).  
 
• Mass-specific flux, JO2/mX [mol∙s
-1∙kg-1]: 
Mass-specific flux is the expression of 
respiration per mass of sample, mX [mg]. 
Chamber volume-specific flux, JV,O2, is 
divided by mass concentration of X in the 
chamber, JO2/mX = JV,O2∙CmX
-1. Cell mass-
specific flux is obtained by dividing flow 
per cell by mass per cell, JO2/mce = 
IO2/Nce∙mNce
-1.  
• Cell volume-specific flux, JO2/VX 
[mol∙s-1∙m-3]: Sample volume-specific flux 
is obtained by expressing respiration per 
volume of sample. 
 
 If size-specific O2 flux is constant and 
independent of sample size, then there is no 
interaction between the subsystems. For 
example, 1.5 mg and 3.0 mg sub-samples of  
muscle tissue respire at identical mass-
specific flux. If mass-specific O2 flux, 
however, changes as a function of the mass of 
a tissue sample, cells or isolated 
mitochondria in the instrumental chamber, 
then the nature of the interaction becomes 
an issue. Therefore, cell concentration must 
be optimized, particularly in experiments 
carried out in wells, considering the 
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confluency of the cell monolayer or clumps of 
cells (Salabei et al 2014). 
 The complexity changes when 
considering the scaling law of respiratory 
physiology. Strong interactions are revealed 
between O2 flow and body mass of an 
individual organism: basal metabolic rate  
(flow) does not increase linearly with body 
mass, whereas maximum mass-specific O2 
flux, ?̇?O2max or ?̇?O2peak, is approximately 
constant across a large range of individual 
body mass (Weibel and Hoppeler 2005). 
Individuals, breeds and species, however, 
deviate substantially from this relationship. 
?̇?O2peak of human endurance athletes is 60 to 
80 mL O2·min-1·kg-1 body mass, converted to 
JO2peak/mNorg of 45 to 60 nmol·s
-1·g-1 (Gnaiger 
2020; Table 6). 
 
4.3. Marker-specific flux: per mitochondrial 
content 
 
Tissues can contain multiple cell populations 
that may have distinct mitochondrial 
subtypes. Mitochondria undergo dynamic 
fission and fusion cycles, and can exist in 
multiple stages and sizes that may be altered 
by a range of factors. The isolation of 
mitochondria (often achieved through 
differential centrifugation) can therefore 
yield a subsample of the mitochondrial types 
present in a tissue, depending on the 
isolation protocols utilized. This possible 
bias should be taken into account when 
planning experiments using isolated 
mitochondria. Different sizes of 
mitochondria are enriched at specific 
centrifugation speeds, which can be used 
strategically for isolation of mitochondrial 
subpopulations. 
 Part of the mitochondrial content of a 
tissue is lost during preparation of isolated 
mitochondria. The fraction of isolated 
mitochondria obtained from a tissue sample 
is expressed as mitochondrial recovery. At a 
high mitochondrial recovery, the fraction of 
isolated mitochondria is more 
representative of the total mitochondrial 
population than in preparations 
characterized by low recovery. 
Determination of the mitochondrial recovery 
and yield is based on measurement of the 
concentration of a mitochondrial marker in 
the stock suspension of isolated 
mitochondria, CmtE,stock, and crude tissue 
homogenate, CmtE,thom, which together 
provide information on the specific 
mitochondrial density in the sample, DmtE 
(Table 4). 
 When discussing concepts of 
normalization, it is essential to consider the 
question posed by the study. If the study 
aims at comparing tissue performance—
such as the effects of a treatment on a specific 
tissue, then normalization for tissue mass or 
protein content is appropriate. However, if 
the aim is to find differences in 
mitochondrial function independent of 
mitochondrial density (Table 4), then 
normalization to a mitochondrial marker is 
Table 5. Sample types, X, abbreviations, and quantification.  
Identity of sample X NX Massa  Volume  mt-Marker 
mitochondrial preparation 
 
 [x] [kg] [kg∙x-1] [m3] [m3∙x-1] [mtEU] 
isolated mitochondria imt  mmt  Vmt  mtE  
tissue homogenate thom  mthom     mtEthom 
permeabilized tissue pti  mpti    mtEpti 
permeabilized muscle fibers pfi  mpfi    mtEpfi 
permeabilized cells pce Npce mpce  mNpce Vpce VNpce mtEpce 
living cellsb ce Nce mce  mNce Vce VNce mtEce 
viable cells vce Nvce mvce  mNvce Vvce VNvce  
dead cells dce Ndce mdce  mNdce Vdce VNdce  
organisms  org Norg morg  mNorg Vorg VNorg  
a Instead of mass, the wet weight or dry weight is frequently stated, Ww or Wd. mX is mass of 
the sample [kg], mNX is mass of the object [kg∙x-1] (Table 4). 
b Total cell count in a living cell population, which consists of viable and dead cells, Nce = Nvce 
+ Ndce, without experimental permeabilization of the plasma membrane. Living cells have 
been called ‘intact’ cells in contrast to permeabilized cells. 
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imperative (Figure 5). One cannot assume 
that quantitative changes in various 
markers—such as mitochondrial proteins—
necessarily occur in parallel with one 
another. It should be established that the 
marker chosen is not selectively altered by 
the performed treatment. In conclusion, the 
normalization must reflect the question 
under investigation to reach a satisfying 
answer. On the other hand, the goal of 
comparing results across projects and 
institutions requires standardization on 
normalization for entry into a databank. 
 
4.3.1. Mitochondrial concentration, CmtE, 
and mitochondrial markers: 
Mitochondrial organelles compose a 
dynamic cellular reticulum in various states 
of fusion and fission. Hence, the definition of 
an ‘amount’ of mitochondria is often 
misconceived: mitochondria cannot be 
counted reliably as a number of occurring 
elementary components. Therefore, 
quantification of the amount of mitochondria 
depends on the measurement of chosen 
mitochondrial markers. ‘Mitochondria are 
the structural and functional elementary units 
of cell respiration’ (Gnaiger 2020). The 
quantity of a mitochondrial marker can 
reflect the amount of mitochondrial 
elementary components, mtE, expressed in 
various mitochondrial elementary units 
[mtEU] specific for each measured mt-
marker (Table 4). However, since 
mitochondrial quality may change in 
response to stimuli—particularly in 
mitochondrial dysfunction (Campos et al 
2017) and after exercise training (Pesta et al 
2011) and during aging (Daum et al 2013)—
some markers can vary while others are 
unchanged: (1) Mitochondrial volume and 
membrane area are structural markers, 
whereas mitochondrial protein mass is 
commonly used as a marker for isolated 
mitochondria. (2) Molecular and enzymatic 
mitochondrial markers (amounts or 
activities) can be selected as matrix markers, 
e.g., citrate synthase activity, mtDNA; mtIM-
markers, e.g., cytochrome c oxidase activity, 
aa3 content, cardiolipin, or mtOM-markers, 
e.g., the voltage-dependent anion channel 
(VDAC), TOM20. (3) Extending the 
measurement of mitochondrial marker 
enzyme activity to mitochondrial pathway 
capacity, ET- or OXPHOS-capacity can be 
considered as an integrative functional 
mitochondrial marker. 
 Depending on the type of mitochondrial 
marker, the mitochondrial elementary 
entity, mtE, is expressed in marker-specific 
units. Mitochondrial concentration in the 
instrumental chamber and mitochondrial 
density in the tissue of origin are quantified 
as (1) a quantity for normalization in 
functional analyses, CmtE, and (2) a 
physiological output that is the result of 
mitochondrial biogenesis and degradation, 
DmtE, respectively (Table 4). It is 
recommended, therefore, to distinguish 
experimental mitochondrial concentration, 
CmtE = mtE∙V-1 and physiological 
mitochondrial density, DmtE = mtE∙mX-1. Then 
mitochondrial density is the amount of 
mitochondrial elementary components per 
mass of tissue, which is a biological variable 
(Figure 5). The experimental variable is 
mitochondrial density multiplied by sample 
mass concentration in the measuring 
chamber, CmtE = DmtE∙CmX, or mitochondrial 
content multiplied by sample number 
concentration, CmtE = mtEX∙CNX (Table 4). 
 
4.3.2. mt-Marker-specific flux, JO2/mtE: 
Volume-specific metabolic O2 flux depends 
on: (1) the sample concentration in the 
volume of the instrumental chamber, CmX, or 
CNX; (2) the mitochondrial density in the 
sample, DmtE = mtE∙mX-1 or mtEX = mtE∙NX-1; 
and (3) the specific mitochondrial activity or 
performance per mitochondrial elementary 
marker, JO2/mtE = JV,O2∙CmtE
-1 [mol∙s-1∙mtEU-1] 
(Table 4). Obviously, the numerical results 
for JO2/mtE vary with the type of mitochondrial 
marker chosen for measurement of mtE and 
CmtE = mtE∙V-1 [mtEU∙m-3]. 
 Different methods for the quantification 
of mitochondrial markers have different 
strengths and weaknesses. Some problems 
are common for all mitochondrial markers, 
mtE: (1) Accuracy of measurement is crucial, 
since even a highly accurate and 
reproducible measurement of chamber 
volume-specific O2 flux results in an 
inaccurate and noisy expression if 
normalized by a biased and noisy 
measurement of a mitochondrial marker. 
This problem is acute in mitochondrial 
respiration because the denominators used 
 
 
  Consortium Communication 
28 of 44 Gnaiger E et al (2020) Bioenerg Commun 2020.1 
 
(the mitochondrial markers) are often small 
moieties of which accurate and precise 
determination is difficult. In contrast, an 
internal marker is used when O2 fluxes 
measured in substrate-uncoupler-inhibitor 
titration protocols are normalized for flux in 
a defined respiratory reference state within 
the assay, which yields flux control ratios, 
FCRs. FCRs are independent of externally 
measured markers and, therefore, are 
statistically robust, considering the 
limitations of ratios in general (Jasienski and 
Bazzaz 1999). FCRs indicate qualitative 
changes of mitochondrial respiratory 
control, with highest quantitative resolution, 
separating the effect of mitochondrial 
density on JO2/mX and IO2/NX from that of 
function per mitochondrial elementary 
marker, JO2/mtE (Pesta et al 2011; Gnaiger 
2020). (2) If mitochondrial quality does not 
change and only the amount of mitochondria 
varies as a determinant of mass-specific flux, 
any marker is equally qualified in principle; 
then in practice selection of the optimum 
marker depends only on the accuracy and 
precision of measurement of the 
mitochondrial marker. (3) If mitochondrial 
flux control ratios change, then there may 
not be any best mitochondrial marker. In 
general, measurement of multiple 
mitochondrial markers enables a 
comparison and evaluation of normalization 
for these mitochondrial markers. 
Particularly during postnatal development, 
the activity of marker enzymes—such as 
cytochrome c oxidase and citrate synthase—
follows different time courses (Drahota et al 
2004). Evaluation of mitochondrial markers 
in healthy controls is insufficient for 
providing guidelines for application in the 
diagnosis of pathological states and specific 
treatments. 
 In line with the concept of the respiratory 
acceptor control ratio (Chance and Williams 
1955a), the most readily applied 
normalization is that of flux control ratios 
and flux control factors (Gnaiger 2009; 
2020). Then, instead of a specific mt-enzyme 
activity, the respiratory activity in a 
reference state serves as the mtE, yielding a 
dimensionless ratio of two fluxes measured 
consecutively in the same respirometric 
titration protocol. Selection of the state of 
maximum flux in a protocol as the reference 
state ― e.g., ET-state in L/E and P/E flux 
control ratios (Gnaiger 2009) ― has the 
advantages of: (1) elimination of 
experimental variability in additional 
measurements, such as determination of 
enzyme activity or tissue mass; (2) 
statistically validated linearization of the 
response in the range of 0 to 1; and (3) 
consideration of maximum flux for 
integrating a large number of metabolic 
steps in the OXPHOS- or ET-pathways. This 
reduces the risk of selecting a functional 
marker that is specifically altered by the 
treatment or pathology, yet increases the 
chance that the highly integrative pathway is 
disproportionately affected, e.g., the 
OXPHOS- rather than ET-pathway in case of 
an enzymatic defect in the phosphorylation-
pathway. In this case, additional information 
can be obtained by reporting flux control 
ratios based on a reference state that 
indicates stable tissue-mass specific flux.  
 Stereological measurement of 
mitochondrial content via two-dimensional 
transmission electron microscopy is 
considered as the gold standard in 
determination of mitochondrial volume 
fractions in cells and tissues (Weibel, 
Hoppeler, 2005). Accurate determination of 
three-dimensional volume by two-
dimensional microscopy, however, is both 
time consuming and statistically challenging 
(Larsen et al 2012). The validity of using 
mitochondrial marker enzymes (citrate 
synthase activity, CI to CIV amount or 
activity) for normalization of flux is limited 
in part by the same factors that apply to flux 
control ratios. Strong correlations between 
various mitochondrial markers and citrate 
synthase activity (Reichmann et al 1985; 
Boushel et al 2007; Mogensen et al 2007) are 
expected in a specific tissue of healthy 
persons and in disease states not specifically 
targeting citrate synthase. Citrate synthase 
activity is acutely modifiable by exercise 
(Tonkonogi et al 1997; Leek et al 2001). 
Evaluation of mitochondrial markers related 
to a selected age and sex cohort cannot be 
extrapolated to provide recommendations 
for normalization in respirometric diagnosis 
of disease, in different states of development 
and aging, different cell types, tissues, and 
species. mtDNA normalized to nDNA via 
qPCR is correlated to functional 
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mitochondrial markers including OXPHOS- 
and ET-capacity in some cases (Puntschart et 
al 1995; Wang et al 1999; Menshikova et al 
2006; Boushel et al 2007; Ehinger et al 
2015), but lack of such correlations have 
been reported (Menshikova et al 2005; 
Schultz and Wiesner 2000; Pesta et al 2011). 
Several studies indicate a strong correlation 
between cardiolipin content and increase in 
mitochondrial function with exercise 
(Menshikova et al 2005; Menshikova et al 
2007; Larsen et al 2012; Faber et al 2014), 
but it has not been evaluated as a general 
mitochondrial biomarker in disease. With no 
single best mitochondrial marker, a good 
strategy is to quantify several different 
biomarkers to minimize the decorrelating 
effects caused by diseases, treatments, or 
other factors. Determination of multiple 
markers, particularly a matrix marker and a 
marker from the mtIM, allows tracking 
changes in mitochondrial quality defined by 
their ratio. 
 
5. Normalization of rate per system 
 
5.1. Flow: per chamber 
 
The instrumental system (chamber) is part 
of the measurement instrument, separated 
from the environment as an isolated, closed, 
open, isothermal or non-isothermal system 
(Table 4). Reporting O2 flows per 
respiratory chamber, IO2 [nmol∙s
-1], restricts 
the analysis to intra-experimental 
comparison of relative differences. 
 
5.2. Flux: per chamber volume 
 
5.2.1. System-specific flux, JV,O2: We 
distinguish between (1) the system with 
volume V and mass m defined by the system 
boundaries, and (2) the sample or objects 
with volume VX and mass mX that are 
enclosed in the instrumental chamber 
(Figure 5). Metabolic O2 flow per object, 
IO2/NX, is the total O2 flow in the system 
divided by the number of objects, NX, in the 
system. IO2/NX increases as the mass of the 
object is increased. Sample mass-specific O2 
flux, JO2/mX should be independent of the 
mass-concentration of the subsample 
obtained from the same tissue or cell culture, 
but system volume-specific O2 flux, JV,O2 (per 
liquid volume of the instrumental chamber), 
increases in proportion to the mass of the 
sample in the chamber. Although JV,O2 
depends on mass-concentration of the 
sample in the chamber, it should be 
independent of the chamber (system) 
volume at constant sample mass- 
concentration. There are practical 
limitations to increasing the mass-
concentration of the sample in the chamber, 
when one is concerned about crowding 
effects and instrumental time resolution. The 
wall of the chamber and the enclosed solid 
stirrer are not counted as part of the chamber 
volume. 
 
5.2.2. Advancement per volume: When the 
reactor volume does not change during the 
reaction, which is typical for liquid phase 
reactions, the volume-specific flux of a 
chemical reaction r is the time derivative of 
the advancement of the reaction per unit 
volume, JV,rB = drξB/dt∙V-1 [(mol∙s-1)∙L-1]. The 
rate of concentration change is dcB/dt  
[(mol∙L-1)∙s-1], where concentration is cB = 
nB∙V-1. There is a difference between (1) JV,rO2 
[mol∙s-1∙L-1] and (2) rate of concentration 
change [mol∙L-1∙s-1]. These merge into a 
single expression only in closed systems. In 
open systems, internal transformations 
(catabolic flux, O2 consumption) are 
distinguished from external flux (such as O2 
supply). External fluxes of all substances are 
zero in closed systems. In a closed chamber 
O2 consumption (internal flux of catabolic 
reactions k; IkO2 [pmol∙s
-1]) causes a decline 
in the amount of O2 in the system, nO2 [nmol]. 
Normalization of these quantities for the 
volume of the system, V [L ≡ dm3], yields 
volume-specific O2 flux, JV,kO2 = IkO2/V 
[nmol∙s-1∙L-1], and O2 concentration, [O2] or 
cO2 = nO2∙V
-1 [µmol∙L-1 = µM = nmol∙mL-1]. 
Instrumental background O2 flux is due to 
external flux into a non-ideal closed 
respirometer, so total volume-specific flux 
has to be corrected for instrumental 
background O2 flux—O2 diffusion into or out 
of the instrumental chamber. JV,kO2 is relevant 
mainly for methodological reasons and 
should be compared with the accuracy of 
instrumental resolution of background-
corrected flux, e.g., ±1 nmol∙s-1∙L-1 (Gnaiger 
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2001). ‘Catabolic’ indicates O2 flux, JkO2, 
corrected for: (1) instrumental background 
O2 flux; (2) chemical background O2 flux due 
to autoxidation of chemical components 
added to the incubation medium; and (3) Rox 
for O2-consuming side reactions unrelated to 
the catabolic pathway k. 
 
6. Conversion of units 
 
Many different units have been used to 
report the O2 consumption rate, OCR (Table 
6). SI base units provide the common 
reference to introduce the theoretical 
principles (Figure 5), and are used with 
appropriately chosen SI prefixes to express 
numerical data in the most practical format, 
with an effort towards unification within 
specific areas of application (Table 7). 
Reporting data in SI units—including the 
mole [mol], coulomb [C], joule [J], and second 
[s]—should be encouraged, particularly by 
journals that propose the use of SI units. 
 Although volume is expressed as m3 using 
the SI base unit, the litre [dm3] is a 
conventional unit of volume for 
concentration and is used for most solution 
chemical kinetics. If one multiplies IO2/Nce by 
CNce, then the result will not only be the 
amount of O2 [mol] consumed per time [s-1] 
in one litre [L-1], but also the change in O2 
concentration per second (for any volume of 
an ideally closed system). This is ideal for 
kinetic modeling as it blends with chemical 
rate equations where concentrations are 
typically expressed in mol∙L-1 (Wagner et al 
2011). In studies of multinuclear cells—such 
as differentiated skeletal muscle cells—it is 
easy to determine the number of nuclei but 
not the total number of cells. A generalized 
concept, therefore, is obtained by 
substituting cells by nuclei as the sample 
entity. This does not hold, however, for non-
nucleated platelets. 
 For studies of cells, we recommend that 
respiration be expressed, as far as possible, 
as: (1) O2 flux normalized for a mitochondrial 
marker, for separation of the effects of 
mitochondrial quality and content on cell 
respiration (this includes FCRs as a 
Table 6. Conversion of various formats and units used in respirometry and 
ergometry. e- is the number of electrons or reducing equivalents. zB is the charge number 
of entity B. 
Format 1 Unit                                   ∙ Multiplication factor SI-unit  Notes 
n  ng.atom O∙s-1 (2 e-) 0.5 nmol O2∙s-1  
n  ng.atom O∙min-1 (2 e-) 8.33 pmol O2∙s-1  
n  natom O∙min-1 (2 e-) 8.33 pmol O2∙s-1  
n  nmol O2∙min-1 (4 e-) 16.67 pmol O2∙s-1  
n  nmol O2∙h-1 (4 e-) 0.2778 pmol O2∙s-1  
V to n mL O2∙min-1 at STPDa 0.744 µmol O2∙s-1 1 
e to n W = J/s at -470 kJ/mol O2 -2.128 µmol O2∙s-1  
e to n mA = mC∙s-1  (zH+ = 1) 10.36 nmol H+∙s-1 2 
e to n mA = mC∙s-1  (zO2 = 4) 2.59 nmol O2∙s-1 2 
n to e nmol H+∙s-1  (zH+ = 1) 0.09649 mA 3 
n to e nmol O2∙s-1  (zO2 = 4) 0.38594 mA 3 
1 At standard temperature and pressure dry (STPD: 0 °C = 273.15 K and 1 atm = 101.325 
kPa = 760 mmHg), the molar volume of an ideal gas, Vm, and Vm,O2 is 22.414 and 22.392 
L∙mol-1, respectively. Rounded to three decimal places, both values yield the conversion 
factor of 0.744. For comparison at normal temperature and pressure dry (NTPD: 20 °C), 
Vm,O2 is 24.038 L∙mol
-1. Note that the SI standard pressure is 100 kPa. 
2 The multiplication factor is 106/(zB∙F). 
3 The multiplication factor is zB∙F/106. 
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normalization for a functional mitochondrial 
marker); (2) O2 flux in units of cell volume or 
mass, for comparison of respiration of cells 
with different cell size (Renner et al 2003) 
and with studies on tissue preparations, and 
(3) O2 flow in units of attomole (10-18 mol) of 
O2 consumed per second by each cell 
[amol∙s-1∙cell-1], numerically equivalent to 
[pmol∙s-1∙10-6 cells]. This convention allows 
information to be easily used when 
designing experiments in which O2 flow must 
be considered. For example, to estimate the 
volume-specific O2 flux in an instrumental 
chamber that would be expected at a 
particular cell number concentration, one 
simply needs to multiply the flow per cell by 
the number of cells per volume of interest. 
This provides the amount of O2 [mol] 
consumed per time [s-1] per unit volume [L-
1]. At an O2 flow of 100 amol∙s-1∙cell-1 and a 
cell concentration of 109 cells∙L-1 (106 
cells∙mL-1), the volume-specific O2 flux is 100 
nmol∙s-1∙L-1 (100 pmol∙s-1∙mL-1). 
 ET-capacity in human cell types including 
HEK 293, primary HUVEC, and fibroblasts 
ranges from 50 to 180 amol∙s-1∙cell-1, 
measured in living cells in the noncoupled 
state (Gnaiger 2020). At 100 amol∙s-1∙cell-1 
corrected for Rox, the current across the mt- 
membranes, IH+e, approximates 193 pA∙cell-1 
or 0.2 nA per cell. See Rich (2003) for an 
extension of quantitative bioenergetics from 
the molecular to the human scale, with a 
transmembrane proton flux equivalent to 
520 A in an adult at a catabolic power of -110 
W. Modelling approaches illustrate the link 
between protonmotive force and currents 
(Willis et al 2016). 
 We consider isolated mitochondria as 
powerhouses and proton pumps as 
molecular machines to relate experimental 
results to energy metabolism of living cells. 
The cellular P»/O2 based on oxidation of 
glycogen is increased by the glycolytic 
(fermentative) substrate-level 
phosphorylation of 3 P»/Glyc or 0.5 mol P» 
for each mol O2 consumed in the complete 
oxidation of a mol glycosyl unit (Glyc). 
Adding 0.5 to the mitochondrial P»/O2 ratio 
of 5.4 yields a bioenergetic cell physiological 
P»/O2 ratio close to 6. Two NADH 
equivalents are formed during glycolysis and 
transported from the cytosol into the 
mitochondrial matrix, either by the malate-
aspartate shuttle or by the glycerophosphate 
shuttle (Figure 1a) resulting in different 
theoretical yields of ATP generated by 
mitochondria, the energetic cost of which 
potentially must be taken into account. 
Considering also substrate-level 
Table 7. Conversion of units with preservation of numerical values. 
Name Frequently used unit Equivalent unit Notes 
volume-specific flux, JV,O2 pmol∙s-1∙mL-1 nmol∙s-1∙L-1 1 
 mmol∙s-1∙L-1 mol∙s-1∙m-3  
cell-specific flow, IO2/Nce pmol∙s-1∙10-6 cells amol∙s-1∙cell-1 2 
 pmol∙s-1∙10-9 cells zmol∙s-1∙cell-1 3 
cell number concentration, CNce  106 cells∙mL-1 109 cells∙L-1  
mitochondrial protein concentration, CmtE 0.1 mg∙mL-1 0.1 g∙L-1  
mass-specific flux, JO2/m pmol∙s-1∙mg-1 nmol∙s-1∙g-1 4 
catabolic power, Pk µW∙10-6 cells pW∙cell-1 1 
volume  1,000 L m3 (1,000 kg)  
 L dm3 (kg)  
 mL cm3 (g)  
 µL mm3 (mg)  
 fL µm3 (pg) 5 
amount of substance concentration M = mol∙L-1 mol∙dm-3  
1 pmol: picomole = 10-12 mol 4 nmol: nanomole = 10-9 mol 
2 amol: attomole = 10-18 mol 5 fL: femtolitre = 10-15 L 
3 zmol: zeptomole = 10-21 mol  
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phosphorylation in the TCA cycle, this high 
P»/O2 ratio not only reflects proton 
translocation and OXPHOS studied in 
isolation, but integrates mitochondrial 
physiology with energy transformation in 
the living cell (Gnaiger 1993a). 
 
7. Conclusions 
 
Catabolic cell respiration is the process of 
exergonic and exothermic energy 
transformation in which scalar redox 
reactions are coupled to vectorial ion 
translocation across a semipermeable 
membrane, which separates the small 
volume of a bacterial cell or mitochondrion 
from the larger volume of its surroundings. 
The electrochemical exergy can be partially 
conserved in the phosphorylation of ADP to 
ATP or in ion pumping, or dissipated in an 
electrochemical short-circuit. Respiration is 
thus clearly distinguished from fermentation 
as the counterparts of cellular core energy 
metabolism. An O2 flux balance scheme 
illustrates the relationships and general 
definitions (Figures 1 and 2). 
 
Box 3: Recommendations for studies 
with mitochondrial preparations 
 
● Normalization of respiratory rates should 
be provided as far as possible:  
 
A. Sample normalization 
1.  Object-specific biophysical normalization: 
on a per organism or per cell basis as O2 
flow; this may not be possible when 
dealing with coenocytic organisms, e.g., 
filamentous fungi, or tissues without 
cross-walls separating individual cells, 
e.g., muscle fibers. 
2. Size-specific cellular normalization: per g 
protein; per organism-, cell- or tissue-
mass as mass-specific O2 flux; per cell 
volume as cell volume-specific flux. 
3. Mitochondrial normalization: per 
mitochondrial marker as mt-specific flux.  
 
B. Chamber normalization 
1.  Chamber volume-specific flux, JV 
[pmol∙s-1∙mL-1], is reported for quality 
control in relation to instrumental 
sensitivity and limit of detection of 
volume-specific flux. 
2. Sample concentration in the instrumental 
chamber is reported as number 
concentration, mass concentration, or 
mitochondrial concentration; this is a 
component of the measuring conditions. 
With information on cell size and the use 
of multiple normalizations, maximum 
potential information is available (Renner 
et al 2003; Wagner et al 2011; Gnaiger 
2020). Reporting flow in a respiratory 
chamber [nmol∙s-1] is discouraged, since it 
restricts the analysis to intra-
experimental comparison of relative 
(qualitative) differences.  
● Catabolic mitochondrial respiration is 
distinguished from residual O2 
consumption. Fluxes in mitochondrial 
coupling states should be, as far as 
possible, corrected for residual O2 
consumption. 
● Different mechanisms of uncoupling 
should be distinguished by defined terms. 
The tightness of coupling relates to these 
uncoupling mechanisms, whereas the 
coupling stoichiometry varies as a 
function the substrate type involved in 
ET-pathways with either three or two 
redox proton pumps operating in series. 
Separation of tightness of coupling from 
the pathway-dependent coupling 
stoichiometry is possible only when the 
substrate type undergoing oxidation 
remains the same for respiration in LEAK-
, OXPHOS-, and ET-states. In studies of the 
tightness of coupling, therefore, simple 
substrate-inhibitor combinations should 
be applied to exlcude a shift in substrate 
competition that may occur when 
providing physiological substrate 
cocktails. 
● In studies of isolated mitochondria, the 
mitochondrial recovery and yield should 
be reported. Experimental criteria such as 
transmission electron microscopy for 
evaluation of purity versus integrity 
should be considered. Mitochondrial 
markers—such as citrate synthase 
activity as an enzymatic matrix marker—
provide a link to the tissue of origin on the 
basis of calculating the mitochondrial 
recovery, i.e., the fraction of 
mitochondrial marker obtained from a 
unit mass of tissue. Total mitochondrial 
protein is frequently applied as a 
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mitochondrial marker, which is restricted 
to isolated mitochondria. 
● In studies of permeabilized cells, the 
viability of the cell culture or cell 
suspension of origin should be reported. 
Normalization should be evaluated for 
total cell count or viable cell count. 
● Terms and symbols are summarized in 
Table 8. Their use will facilitate 
transdisciplinary communication and 
support further development of a 
consistent theory of bioenergetics and 
mitochondrial physiology. Technical 
terms related to and defined with normal 
words can be used as index terms in data 
repositories, support the creation of 
ontologies towards semantic information 
processing (MitoPedia), and help in 
communicating analytical findings as 
impactful data-driven stories. ‘Making 
data available without making it 
understandable may be worse than not 
making it available at all’ (National 
Academies of Sciences, Engineering, and 
Medicine 2018). Success will depend on 
taking further steps: (1) exhaustive text-
mining considering Omics data and 
functional data; (2) network analysis of 
Omics data with bioinformatics tools; (3) 
cross-validation with distinct 
bioinformatics approaches; (4) 
correlation with physiological data; (5) 
guidelines for biological validation of 
network data. This is a call to carefully 
contribute to FAIR principles (Findable, 
Accessible, Interoperable, Reusable) for 
the sharing of scientific data. 
 
 Experimentally, respiration is separated 
in mitochondrial preparations from the 
interactions with the fermentative pathways 
of the living cell. OXPHOS analysis is based on 
the study of mitochondrial preparations 
complementary to bioenergetic 
investigations of (1) submitochondrial 
particles and molecular structures, (2) living 
cells, and (3) organisms—from model 
organisms to the human species including 
healthy and diseased persons (patients). 
Different mechanisms of respiratory 
uncoupling have to be distinguished (Figure 
3). Metabolic fluxes measured in defined 
coupling and pathway control states 
(Figures 5 and 6) provide insights into the 
meaning of cellular and organismic 
respiration.  
 
 
Table 8. Terms, symbols, and units. SI base units are used, except for the liter [L = dm3] 
 
 
Term Symbol Unit  Links and comments 
 
 
alternative quinol oxidase AOX  Fig. 1B 
adenosine monophosphate AMP  2 ADP ↔ ATP+AMP 
adenosine diphosphate ADP  Tab. 1; Fig. 1, 2, 5 
adenosine triphosphate ATP  Fig. 2, 5 
adenylates AMP, ADP, ATP Section 2.5.1 
amount of substance B nB [mol]  
ATP yield per O2 YP»/O2  P»/O2 ratio measured in any 
respiratory state 
catabolic reaction k  Fig. 1, 3 
catabolic respiration JkO2 varies Fig. 1, 3 
cell concentration (mass) Cmce [kg∙L-1] Tab. 4 
cell concentration (number) CNce [x∙L-1] Tab. 4 
cell respiration JrO2 varies Overview 
cell viability index VI  VI = Nvce∙Nce-1 = 1- Ndce∙Nce-1 
charge number of entity B zB  Tab. 6; zO2 = 4 
Complexes I to IV CI to CIV  respiratory ET Complexes are 
redox proton pumps; Fig. 1B; 
F1FO-ATPase is not a redox 
proton pump of the ETS, hence 
the term CV is not recommended 
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concentration of substance B cB = nB∙V-1; [B] [mol∙L-1]  Box 2 
coupling control state CCS  Section 2.4.1 
dead cells dce  Tab. 5 
electric format e [C] Tab. 6 
electron transfer, state ET  Tab. 1; Fig. 2B, 4 (State 3u) 
electron transfer system ETS  Fig. 2B, 4 (electron transport 
chain) 
ET-capacity E varies rate; Tab. 1; Fig. 2 
ET-excess capacity E-P varies Fig. 2 
flow, for substance B IB [mol∙s-1]  system-related extensive quantity; 
Fig. 5 
flux, for substance B JB varies size-specific quantitiy; Fig. 5 
inorganic phosphate Pi  Fig. 1C 
inorganic phosphate carrier PiC  Fig. 1C 
isolated mitochondria imt  Tab. 5 
living cells ce  Tab. 5 (intact cells) 
LEAK-state  LEAK  Tab. 1; Fig. 2 (compare State 4) 
LEAK-respiration L varies rate; Tab. 1; Fig. 2 
mass format m [kg] Tab. 4; Fig. 5 
mass of sample or object X mX or mNX [kg] or [kg∙x-1] Tab. 4 
mass, dry mass md [kg] or [kg∙x-1] Fig. 5 (dry weight) 
mass, wet mass mw [kg] or [kg∙x-1] Fig. 5 (wet weight) 
MITOCARTA         https://www.broadinstitute.org/scientific-
community/science/programs/meta
bolic-disease-
program/publications/mitocarta/mi
tocarta-in-0  
MitoPedia        http://www.bioblast.at/index.php/MitoPedia 
mitochondria or mitochondrial mt  Box 1 
mitochondrial DNA mtDNA  Box 1 
mitochondrial concentration CmtE = mtE∙V-1  [mtEU∙m-3]  Tab. 4 
mitochondrial content mtEX  [mtEU∙x-1]  mtEX = mtE∙NX-1; Tab. 4 
mitochondrial density DmtE = mtE∙mX-1 [mtEU∙kg-1] specific mt-density in tissue; Tab. 
4 
mitochondrial  
 elementary marker mtE [mtEU] quantity of mt-marker; Tab. 4 
mitochondrial elementary unit mtEU varies  specific units for mt-marker; Tab. 
4 
mitochondrial inner membrane  mtIM   Fig. 1; Box 1 (MIM) 
mitochondrial outer membrane  mtOM   Fig. 1; Box 1 (MOM) 
mitochondrial recovery YmtE  fraction of mtE recovered from the 
tissue sample in imt-stock 
mitochondrial yield YmtE/m [mtEU∙kg-1] mt-yield in imt-stock per m of 
tissue sample; YmtE/m = YmtE ∙ DmtE 
molar format n [mol] Tab. 6 
negative neg  Fig. 2 
number concentration of X CNX [x∙m-3]  Tab. 4 
number format N [x] Tab. 4; Fig. 5 
number of cells Nce [x] total cell count of living cells, Nce 
= Nvce + Ndce; Tab. 5 
number of dead cells Ndce [x] non-viable cells, loss of plasma 
membrane barrier function; Tab. 
5 
number of entities X NX [x]  Tab. 4; Fig. 5 
number of entity B NB [x] Tab. 4 
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number of viable cells Nvce [x] viable cells, intact plasma mem-
brane barrier function; Tab. 5 
organisms org  Tab. 5 
oxidative phosphorylation OXPHOS  Tab. 1; Fig. 2 
OXPHOS-state OXPHOS  Tab. 1 (State 3 at kinetically-
saturating [ADP] and [Pi]) 
OXPHOS-capacity P varies rate; Tab. 1; Fig. 2 
oxygen concentration cO2 = nO2∙V
-1 [mol∙m-3]  [O2]; Section 3.2 
oxygen flux, in reaction r JrO2 varies Overview 
pathway control state PCS  Section 2.2 
permeability transition mtPT  Fig. 3; Section 2.4.3 (MPT) 
permeabilized cells pce  experimental permeabilization of 
plasma membrane; Tab. 5 
permeabilized muscle fibers pfi  Tab. 5 
permeabilized tissue pti  Tab. 5 
phosphorylation of ADP to ATP P»  Section 2.2 
P»/O2 ratio P»/O2   mechanistic YP»/O2, calculated from 
pump stoichiometries; Fig. 2B 
positive pos  Fig. 2 
proton in the negative compartment H+neg  Fig. 2 
proton in the positive compartment H+pos  Fig. 2 
protonmotive force pmF [V] Fig 1, 2A, 4; Tab. 1 
rate of electron transfer in ET-state E varies ET-capacity; Tab. 1 
rate of LEAK-respiration L varies Tab. 1: L(n), L(T), L(Omy) 
rate of oxidative phosphorylation P varies OXPHOS-capacity; Tab. 1 
rate of residual oxygen consumption Rox  Tab. 1; Overview 
residual oxygen consumption ROX; Rox  state ROX; rate Rox; Tab. 1 
respiratory supercomplex SCInIIInIVn   supramolecular assemblies with 
variable copy numbers (n) of CI, 
CIII and CIV; Box 1 
substrate concentration at  
 half-maximal rate c50 [mol∙m-3] Section 2.1.2 
substrate-uncoupler-inhibitor- 
 titration SUIT  Section 2.2 
tissue homogenate thom  Tab. 5 
viable cells vce  Tab. 5 
volume V [L] Tab. 7 
volume format V [L] Tab. 6 
volume of sample or object X VX or VNX [L] or [L∙x-1] Tab. 6 
 
 
 
 The optimal choice for expressing 
mitochondrial and cell respiration as O2 flow 
per biological sample, and normalization for 
specific tissue-markers (volume, mass, 
protein) and mitochondrial markers 
(volume, protein, content, mtDNA, activity of 
marker enzymes, respiratory reference 
state) is guided by the scientific question 
under study. Interpretation of the data 
depends critically on appropriate 
normalization (Figure 5). 
 MitoEAGLE can serve as a gateway to 
better diagnose mitochondrial respiratory 
adaptations and defects linked to genetic 
variation, age-related health risks, sex-
specific mitochondrial performance, lifestyle 
with its effects on degenerative diseases, and 
thermal and chemical environment. The 
present recommendations on coupling 
control states and rates are focused on 
studies using mitochondrial preparations 
(Box 3). These will be extended in a series of 
reports on pathway control of mitochondrial 
respiration, respiratory states and rates in 
living cells, respiratory flux control ratios, 
and harmonization of experimental 
procedures. 
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